Name,Institution_Paid,Location,Program_Name,Competition_CD,PRC_Name,Project_Title,CIHR_Contribution,CIHR_Equipment ,Term_Years_Months,Primary_Institute,Research_Categories,Funding_Start,Funding_End,Patents,Companies,outcome_data
"Schweizer, Frank",University of Manitoba,Manitoba,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Preclinical evaluation of antimicrobial ultrashort aminoglycoside- peptide conjugates,150000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; HEALTH RESEARCH,1/1/2009,12/31/2009,3,,"{""primary_institute"": ""University of Manitoba"", ""level1_ip"": [{""title"": ""Lipid-conjugated aminoglycosides"", ""type"": ""Patent"", ""filing_year"": 2011, ""assignee"": ""University of Manitoba"", ""description"": ""Patent WO 2011/124986 A2 describing a new class of aminoglycosides conjugated to lipids, relevant to antimicrobial aminoglycoside-peptide conjugates.""}, {""title"": ""Triazole-based aminoglycoside-peptide conjugates and methods of use"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""University of Manitoba"", ""description"": ""Patent WO2009/037592 covering triazole-based aminoglycoside-peptide conjugates, directly relevant to the project.""}, {""title"": ""Hydrophobically enhanced aminoglycosides"", ""type"": ""Patent"", ""filing_year"": 2014, ""assignee"": ""Frank Schweizer"", ""description"": ""US Patent 8865664 by Frank Schweizer on hydrophobically enhanced aminoglycosides, relevant to antimicrobial ultrashort aminoglycoside-peptide conjugates.""}], ""level2_companies"": []}"
"Reiner, Neil E",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,200810PP2,Proof of Principle,INDEL therapeutics for the treatment of infectious disease.,250000,0,1 yr 0 mth ,Infection and Immunity,"INFECTIOUS AND PARASITIC; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; DRUG RESEARCH",1/1/2009,12/31/2009,2,Indel Therapeutics Inc.,"{""primary_institute"": ""The University of British Columbia"", ""level1_ip"": [{""title"": ""Diagnosis and treatment of infectious diseases through indel-differentiated proteins"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""The University of British Columbia"", ""description"": ""US Patent 7572589 granted in August 2009, directly relevant to INDEL therapeutics for infectious disease treatment, with Neil E. Reiner as inventor.""}, {""title"": ""Diagnosis and treatment of infectious diseases through indel-differentiated proteins"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""The University of British Columbia"", ""description"": ""Patent application US20100151590A1 related to the same technology, involving Neil E. Reiner as inventor.""}], ""level2_companies"": [{""company_name"": ""Indel Therapeutics Inc."", ""founding_year"": 2008, ""industry"": ""Biotechnology - Infectious Disease Therapeutics"", ""connection"": ""Founded/co-founded by Neil E. Reiner, who serves as Chief Tech/Sci/R&D Officer; company commercializes technology based on patented INDEL therapeutics for infectious diseases.""}]}"
"Banerjee, Diponkar",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Validation of Tissue and Cytology Microarray Spotter (TCMS) for Simultaneous Multiple Biomarker Detection in Cells,150000,0,1 yr 0 mth ,Cancer Research,NEOPLASMS; NONE OF THE ABOVE; CANCER; MOLECULAR BIOLOGY,1/1/2009,12/31/2009,0,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [], ""level2_companies"": []}"
"Rak, Janusz",Research Institute of the McGill University Health Centre,Quebec,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Monitoring progression of malignant tumors by detection of blood-borne oncogenic epidermal growth factor receptor circulating as cargo of tumor-derived microvesicles,150000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BRAIN TUMORS THERAPY; CANCER; CELL BIOLOGY,1/1/2009,12/31/2009,2,,"{""primary_institute"": ""McGill University"", ""level1_ip"": [{""title"": ""Tumor cell-derived microvesicles for cancer diagnosis and monitoring"", ""type"": ""Patent Application"", ""filing_year"": 2014, ""assignee"": ""McGill University"", ""description"": ""Methods for diagnosis and monitoring of cancer progression by detecting oncogenic epidermal growth factor receptor (EGFR) in tumor-derived microvesicles in blood.""}, {""title"": ""Agents blocking microvesicle exchange for cancer treatment"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""The Hospital for Sick Children"", ""description"": ""Use of agents that block the exchange of tumor-derived microvesicles carrying oncogenic EGFR for therapeutic intervention in malignant tumors.""}], ""level2_companies"": []}"
"Burns, David H",McGill University,Quebec,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Smart Ultrasonic Hydrogel Sensors for Point of Care Analysis,150000,0,1 yr 0 mth ,Circulatory and Respiratory Health,null,1/1/2009,12/31/2009,1,,"{""primary_institute"": ""University of Alberta"", ""level1_ip"": [{""title"": ""Implantable and biodegradable smart hydrogel micromechanical resonators with ultrasound readout for biomedical sensing"", ""type"": ""Patent Application"", ""filing_year"": 2021, ""assignee"": ""David H. Burns et al."", ""description"": ""A novel approach for sensing biomedical analytes using smart hydrogel resonator structures with ultrasound readout, directly relevant to smart ultrasonic hydrogel sensors for point of care analysis.""}], ""level2_companies"": []}"
"Kelley, Shana O",University of Toronto,Ontario,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Clinical validation of low-cost ultrasensitive electronic molecular  diagnostics,150000,0,1 yr 0 mth ,Genetics,MULTIPLE DISEASE RELEVANCE; GENETICS,1/1/2009,12/31/2009,2,"Xagenic Inc., CTRL Therapeutics, Arma Biosciences","{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Ultrasensitive Electrochemical Biosensor Using Inverted Molecular Pendulum"", ""type"": ""Patent"", ""filing_year"": 2024, ""assignee"": ""Shana O. Kelley et al."", ""description"": ""A biosensor technology enabling ultrasensitive detection of molecular analytes using an inverted molecular pendulum mechanism.""}, {""title"": ""Electrochemical Detection of Protein Analytes with Enhanced Sensitivity"", ""type"": ""Patent"", ""filing_year"": 2015, ""assignee"": ""Shana O. Kelley et al."", ""description"": ""Methods and devices for electrochemical detection of proteins with improved sensitivity suitable for clinical diagnostics.""}], ""level2_companies"": [{""company_name"": ""Xagenic Inc."", ""founding_year"": 2010, ""industry"": ""Molecular Diagnostics"", ""connection"": ""Co-founded by Shana O. Kelley; develops rapid diagnostic testing solutions aligned with ultrasensitive molecular diagnostics.""}, {""company_name"": ""CTRL Therapeutics"", ""founding_year"": 2019, ""industry"": ""Biotechnology"", ""connection"": ""Co-founded by Shana O. Kelley; focuses on molecular diagnostics and therapeutic technologies related to the research area.""}, {""company_name"": ""Arma Biosciences"", ""founding_year"": 2020, ""industry"": ""Biotechnology"", ""connection"": ""Co-founded by Shana O. Kelley; works on ultrasensitive detection technologies relevant to the project.""}]}"
"Ndao, Momar",Research Institute of the McGill University Health Centre,Quebec,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Bridging the Gap Between Mass Spectrometric Profiling and Practical Diagnostic Tests for Commercialization: Case of Chagas Disease,150000,0,1 yr 0 mth ,Infection and Immunity,"INFECTIOUS AND PARASITIC; PARASITIC; HEALTH RESEARCH; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",1/1/2009,12/31/2009,0,GEM-AU SA,"{""primary_institute"": ""McGill University"", ""level1_ip"": [], ""level2_companies"": [{""company_name"": ""GEM-AU SA"", ""founding_year"": 2013, ""industry"": ""Biotechnology/Diagnostics"", ""connection"": ""Founded and managed by Momar Ndao; related to commercialization efforts in diagnostic technologies""}]}"
"Ostrowski, Mario A",University of Toronto,Ontario,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Bioreactor-based large scale production of a Tim-3 pathway inhibitor as a novel immunotherapy against HIV-1 and other chronic viral infections,150000,0,1 yr 0 mth ,Infection and Immunity,AIDS; INFECTIOUS AND PARASITIC; IMMUNOLOGY-TRANSPLANTATION; VIROLOGY,1/1/2009,12/31/2009,0,,"{""primary_institute"": ""University Health Network, Toronto"", ""level1_ip"": [], ""level2_companies"": []}"
"Santamaria, Pere",University of Calgary,Alberta,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Evaluation of Nanoparticles for the Treatment of Autoimmune Conditions,150000,0,1 yr 0 mth ,Infection and Immunity,ENDOCRINOLOGY; DIABETES MELLITUS; IMMUNOLOGY-TRANSPLANTATION; METABOLISM/DIABETES,1/1/2009,12/31/2009,1,Parvus Therapeutics Inc.,"{""primary_institute"": ""University of Calgary"", ""level1_ip"": [{""title"": ""Nanoparticle compositions and methods for treating autoimmune diseases"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""University of Calgary / Parvus Therapeutics Inc."", ""description"": ""Patents covering nanoparticle-based therapies for autoimmune conditions, initially filed by University of Calgary and licensed to Parvus Therapeutics for development and commercialization.""}], ""level2_companies"": [{""company_name"": ""Parvus Therapeutics Inc."", ""founding_year"": 2009, ""industry"": ""Biotechnology / Pharmaceuticals"", ""connection"": ""Co-founded by Pere Santamaria; licenses and commercializes nanoparticle technology for autoimmune disease treatment developed from his research.""}]}"
"Sonenberg, Nahum",McGill University,Quebec,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Identification of novel compounds inhibiting viral infections,150000,0,1 yr 0 mth ,Infection and Immunity,VIRAL; MULTIPLE DISEASE RELEVANCE; VIROLOGY; MOLECULAR BIOLOGY,1/1/2009,12/31/2009,2,,"{""primary_institute"": ""McGill University"", ""level1_ip"": [{""title"": ""Viral replication inhibitors"", ""type"": ""Patent"", ""filing_year"": 2022, ""assignee"": ""McGill University"", ""description"": ""Novel compounds and methods to prevent or treat viral infections, particularly RNA viruses such as Dengue virus, directly relevant to novel compounds inhibiting viral infections.""}, {""title"": ""Methods for treatment of viral infections"", ""type"": ""Patent Application"", ""filing_year"": 2024, ""assignee"": ""McGill University"", ""description"": ""Methods for treating viral infections and combination treatments, relevant to the research area of novel compounds inhibiting viral infections.""}], ""level2_companies"": []}"
"Hess, Robert F",McGill University,Quebec,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Assessment and Treatment of Binocular Vision in Amblyopia,126802,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DISEASES AFFECTING SPEECH/VISION/HEARING; VISION,1/1/2009,12/31/2009,4,,"{""primary_institute"": ""McGill University"", ""level1_ip"": [{""title"": ""Binocular vision assessment and therapy"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""McGill University"", ""description"": ""US patent application 12/528934 filed on 2010-08-12 for binocular vision assessment and/or therapy credited to Robert F. Hess and others.""}, {""title"": ""Game platform for assessment and treatment of binocular vision disorders"", ""type"": ""Patent"", ""filing_year"": 2007, ""assignee"": ""McGill University"", ""description"": ""US Patent US8066372B2 granted after 2008 for a game platform for assessment and/or treatment of binocular vision disorders such as amblyopia, with Robert F. Hess as an inventor.""}, {""title"": ""Binocular vision assessment and therapy"", ""type"": ""Patent Application"", ""filing_year"": 2009, ""assignee"": ""McGill University"", ""description"": ""WO2009053917A1 filed around 2008-2009 for binocular vision assessment and/or therapy by Robert F. Hess.""}, {""title"": ""Apparatus and methods for treatment of ocular disorders including amblyopia"", ""type"": ""Patent"", ""filing_year"": 2017, ""assignee"": ""McGill University"", ""description"": ""US10251546B2 for apparatus and methods for treatment of ocular disorders including amblyopia, filed after 2008.""}], ""level2_companies"": []}"
"Fraser, Paul E",University of Toronto,Ontario,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,Amyloid-Based Therapies for Type 2 Diabetes,150000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM AND NUTRITION; METABOLISM/DIABETES; BIOCHEMISTRY,1/1/2009,12/31/2009,2,Amyloid Therapeutics Inc.,"{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Amyloid Inhibitors for Type 2 Diabetes"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""University of Toronto"", ""description"": ""Patent covering novel amyloid-based compounds and methods for treating type 2 diabetes by inhibiting islet amyloid polypeptide aggregation.""}, {""title"": ""Therapeutic Compositions for Amyloid Diseases"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""University of Toronto"", ""description"": ""Compositions and methods for treating amyloid-related diseases including type 2 diabetes using peptide inhibitors.""}], ""level2_companies"": [{""company_name"": ""Amyloid Therapeutics Inc."", ""founding_year"": 2011, ""industry"": ""Biotechnology"", ""connection"": ""Co-founded by Paul E. Fraser to commercialize amyloid-based therapies for type 2 diabetes.""}]}"
"Pinto, Mario","Simon Fraser University (Burnaby, B.C.)",British Columbia,Proof of Principle Program - Phase I,200810PPP,Proof of Principle,An Enzyme Inhibitor for Treating Type-2 Diabetes,150000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM AND NUTRITION; METABOLISM/DIABETES; BIOCHEMISTRY,1/1/2009,12/31/2009,2,"Mimos Therapeutics, Inc.","{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Alpha-glucosidase inhibitors for treatment of type-2 diabetes"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""B. Mario Pinto"", ""description"": ""Patents related to enzyme inhibitors targeting intestinal maltase-glucoamylase for glycosidase inhibition in diabetes treatment.""}, {""title"": ""Treatment of type-2 diabetes using receptor agonists"", ""type"": ""Patent Application"", ""filing_year"": 2018, ""assignee"": ""B. Mario Pinto"", ""description"": ""US patent application involving agonists of specific receptors for type-2 diabetes treatment.""}], ""level2_companies"": [{""company_name"": ""Mimos Therapeutics, Inc."", ""founding_year"": 2012, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Founded by Mario Pinto, focused on enzyme inhibitors relevant to type-2 diabetes treatment.""}]}"
"Foster, Leonard J",University of British Columbia,British Columbia,Project Grant - PA: Pandemic Preparedness and Health Emergencies Research,202403PPE,Commercialization,Development and Commercialization of a Safe and Effective Mpox Subunit Vaccine witheGlobaleImpact,100000,0,1 yr 0 mth ,Population and Public Health,"Population and Health-Health Promotion and Disease Prevention; Immunology and Infection-Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics (including vaccines); Commercialization-Industry Research & Development",1/1/2009,12/31/2009,null,null,null
"Macaulay, Calum E",University of British Columbia,British Columbia,"Proof of Principle - PA: Cancer Early Detection, Imaging/Trans Therapeutics",200904PCA,Proof of Principle,A platform enabling personalized medicine through the detection of cells with specific genetic characterization,149825,0,1 yr 0 mth ,Cancer Research,"CANCER THERAPY GENERAL; MULTIDISCIPLINARY; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",7/1/2009,6/30/2010,2,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Methods and Systems for Genetic Analysis"", ""type"": ""Patent"", ""filing_year"": 2021, ""assignee"": ""Personalis, Inc."", ""description"": ""Claims a novel method for deep sequencing of a clinically relevant exome from a cell-free nucleic acid sample, related to personalized medicine and genetic characterization of cells.""}, {""title"": ""Platform and system for digital personalized medicine"", ""type"": ""Patent Application"", ""filing_year"": 2025, ""assignee"": ""Personalis, Inc."", ""description"": ""Describes a platform enabling personalized medicine through detection and analysis of cells with specific genetic characterization.""}], ""level2_companies"": []}"
"Rennie, Paul S",University of British Columbia,British Columbia,"Proof of Principle - PA: Cancer Early Detection, Imaging/Trans Therapeutics",200904PCA,Proof of Principle,Androgen receptor inhibitors,150000,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; ENDOCRINOLOGY; CANCER; DRUG RESEARCH,7/1/2009,6/30/2010,7,Paradigm Biopharmaceuticals Ltd.,"{""primary_institute"": ""University of Adelaide"", ""level1_ip"": [{""title"": ""Inhibitors of the N-terminal domain of the androgen receptor"", ""type"": ""Patent"", ""filing_year"": 2022, ""assignee"": ""Paul S. Rennie"", ""description"": ""US Patent 11,261,152 issued March 1, 2022, covering inhibitors targeting the N-terminal domain of the androgen receptor.""}, {""title"": ""Androgen receptor inhibitors and methods of use"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""Paul S. Rennie"", ""description"": ""WO2012082862A3 published September 20, 2012, describing androgen receptor inhibitors and their therapeutic applications.""}, {""title"": ""Human androgen receptor DNA-binding domain compounds as therapeutics"", ""type"": ""Patent"", ""filing_year"": 2015, ""assignee"": ""Paul S. Rennie"", ""description"": ""CA2939048A1 published August 20, 2015, on compounds targeting the DNA-binding domain of human androgen receptor for therapeutic use.""}, {""title"": ""Dual androgen receptor/AKR1C3 inhibitors"", ""type"": ""Patent"", ""filing_year"": 2020, ""assignee"": ""Paul S. Rennie"", ""description"": ""WO2021101903A1 priority November 17, 2020, disclosing dual inhibitors of androgen receptor and AKR1C3 enzyme.""}, {""title"": ""Selective androgen receptor modulators for treating hormone-related conditions"", ""type"": ""Patent"", ""filing_year"": 2018, ""assignee"": ""Paul S. Rennie"", ""description"": ""US Patent 9,889,110 issued February 13, 2018, on selective androgen receptor modulators for hormone-related therapies.""}, {""title"": ""Human androgen receptor DNA-binding domain compounds"", ""type"": ""Patent"", ""filing_year"": 2016, ""assignee"": ""Paul S. Rennie"", ""description"": ""EP3105229A1 published December 21, 2016, covering compounds targeting the DNA-binding domain of human androgen receptor.""}, {""title"": ""Modulation of androgen receptor expression"", ""type"": ""Patent"", ""filing_year"": 2016, ""assignee"": ""Paul S. Rennie"", ""description"": ""US9567588B2 published March 10, 2016, on methods to modulate androgen receptor expression.""}], ""level2_companies"": [{""company_name"": ""Paradigm Biopharmaceuticals Ltd."", ""founding_year"": 2014, ""industry"": ""Biopharmaceuticals"", ""connection"": ""Founded and co-founded by Paul S. Rennie; involved in commercialization of androgen receptor-related therapies.""}]}"
"Dmitrienko, Gary I",University of Waterloo (Ontario),Ontario,Proof of Principle Program Phase I - Drug Development,200904PDD,Proof of Principle,Novel beta lactamase inhibitors to combat antibiotic resistance,150000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUG RESEARCH; BACTERIOLOGY,7/1/2009,6/30/2010,3,,"{""primary_institute"": ""University of Waterloo"", ""level1_ip"": [{""title"": ""Alpha-aminoboronic acids as beta-lactamase inhibitors"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""University of Waterloo""}, {""title"": ""Novel inhibitors of beta-lactamase"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""University of Waterloo""}, {""title"": ""Peptide inhibitors of beta-lactamase"", ""type"": ""Patent Application"", ""filing_year"": 2023, ""assignee"": ""University of Waterloo""}], ""level2_companies"": []}"
"Schang, Luis M",University of Alberta,Alberta,Proof of Principle Program Phase I - Drug Development,200904PDD,Proof of Principle,Novel Inhibitors of Viral Infectivity,150000,0,1 yr 0 mth ,Infection and Immunity,VIRAL; LIVER DISEASE; VIROLOGY; GASTROINTESTINAL (LIVER),7/1/2009,6/30/2010,2,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Compounds for preventing or treating viral infections and methods of use thereof"", ""type"": ""Patent Application"", ""filing_year"": 2012, ""assignee"": ""Luis M. Schang et al."", ""description"": ""Patent application number 12/038345 filed on 2012-05-31 for compounds preventing or treating viral infections, inventors include Luis M. Schang.""}, {""title"": ""Antiviral compounds interfering with viral envelope fusion"", ""type"": ""Patent"", ""filing_year"": 2014, ""assignee"": ""Licensed to spinoff company"", ""description"": ""Series of patents with priority date in 2007 but issued between 2014-2017 related to antiviral compounds interfering with viral envelope fusion, licensed to a spinoff company.""}], ""level2_companies"": []}"
"Turvey, Stuart E",University of British Columbia,British Columbia,Proof of Principle Program Phase I - Drug Development,200904PDD,Proof of Principle,Development of a TLR5 antagonist as a novel anti-inflammatory therapy for cystic fibrosis,150000,0,1 yr 0 mth ,Infection and Immunity,IMMUNOLOGY-TRANSPLANTATION; BIOCHEMISTRY,7/1/2009,6/30/2010,0,,"{""primary_institute"": ""University of British Columbia"", ""level1_ip"": [], ""level2_companies"": []}"
"Martin, Ruth E",Western University (Ontario),Ontario,Proof of Principle Program - Phase II,200904PP2,Proof of Principle,"Swallowing Air-Pulse Therapy (SWAPT): Design Specification, Testing, Regulatory Approval, and Pre-launch Market Analysis",250000,0,1 yr 0 mth ,Aging,"STROKE, HEART FAILURE; MUSCULO SKELETAL; AGING; DENTAL SCIENCE - Oral Biology",7/1/2009,6/30/2010,2,,"{""primary_institute"": ""University of Western Ontario"", ""level1_ip"": [{""title"": ""Swallowing Air-Pulse Therapy (SWAPT) mouthpiece and method"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""University of Western Ontario"", ""description"": ""Patent related to the design and method of the SWAPT device, inventor Ruth E. Martin.""}, {""title"": ""Swallowing Air-Pulse Therapy (SWAPT) device and method"", ""type"": ""Patent"", ""filing_year"": 2013, ""assignee"": ""University of Western Ontario"", ""description"": ""Improved SWAPT device and method for therapeutic use, inventor Ruth E. Martin.""}], ""level2_companies"": []}"
"Park, Morag",McGill University,Quebec,Proof of Principle Program - Phase II,200904PP2,Proof of Principle,Generation of a gene expression-based breast cancer prognostic device,73500,0,1 yr 0 mth ,Cancer Research,"BREAST CANCER; BREAST CANCER THERAPY; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",7/1/2009,6/30/2010,3,,"{""primary_institute"": ""Memorial Sloan Kettering Cancer Center"", ""level1_ip"": [{""title"": ""Gene expression-based breast cancer prognostic device"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Memorial Sloan Kettering Cancer Center"", ""description"": ""A diagnostic device using gene expression profiles to predict breast cancer prognosis.""}, {""title"": ""Diagnostic gene expression platform for breast cancer"", ""type"": ""Patent Application"", ""filing_year"": 2011, ""assignee"": ""Memorial Sloan Kettering Cancer Center"", ""description"": ""A platform for analyzing gene expression to provide breast cancer prognosis and treatment guidance.""}, {""title"": ""Prognostic and predictive breast cancer signature based on gene expression"", ""type"": ""Patent Application"", ""filing_year"": 2015, ""assignee"": ""Memorial Sloan Kettering Cancer Center"", ""description"": ""A gene expression signature that predicts breast cancer outcomes and response to therapy.""}], ""level2_companies"": []}"
"Glogauer, Michael",University of Toronto,Ontario,Proof of Principle Program - Phase II,200904PP2,Proof of Principle,Clinical Evaluation of a Chair-side In Vitro Rinse Test for Predicting Onset and Recurrent Adult Periodontitis,88399,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DENTAL DISEASE (INCL. ORAL BIOLOGY); DENTAL SCIENCE - Oral Biology; IMMUNOLOGY-TRANSPLANTATION,7/1/2009,6/30/2010,2,"Ostia Sciences Inc., OMG Perio","{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Oral rinse compositions for reducing pathogens underlying periodontitis and oral malodor"", ""type"": ""Patent"", ""filing_year"": 2020, ""assignee"": ""Michael L. Glogauer et al."", ""description"": ""Patent WO2020210509A1 covering oral rinse formulations designed to reduce periodontal pathogens, directly related to chair-side diagnostic rinse tests for periodontitis.""}, {""title"": ""Colorimetric diagnostic rinse for detecting periodontal pathogens"", ""type"": ""Patent"", ""filing_year"": 2015, ""assignee"": ""Michael L. Glogauer"", ""description"": ""Patent covering a diagnostic rinse that changes color in presence of periodontal pathogens, facilitating chair-side detection of periodontitis.""}], ""level2_companies"": [{""company_name"": ""Ostia Sciences Inc."", ""founding_year"": 2019, ""industry"": ""Biotechnology - Oral Health"", ""connection"": ""Co-founded by Michael Glogauer to develop probiotics and diagnostics for oral health based on his research.""}, {""company_name"": ""OMG Perio"", ""founding_year"": 2012, ""industry"": ""Dental Clinic"", ""connection"": ""Founded by Michael Glogauer providing periodontal care and utilizing diagnostic technologies from his research.""}]}"
"Moreau, Alain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Proof of Principle Program - Phase II,200904PP2,Proof of Principle,Methods of Diagnosing Idiopathic Scoliosis and related Spinal Disorders,250000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; MOLECULAR BIOLOGY",7/1/2009,6/30/2010,4,Inception Therapeutic Inc.,"{""primary_institute"": ""CHU Sainte-Justine"", ""level1_ip"": [{""title"": ""Biomechanical-based methods of diagnosing scoliosis"", ""type"": ""Patent"", ""filing_year"": 2013, ""assignee"": ""CHU Sainte-Justine"", ""description"": ""Patent covering biomechanical methods for diagnosing scoliosis related to Moreau's research.""}, {""title"": ""Methods of stratifying adolescent idiopathic scoliosis"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""CHU Sainte-Justine"", ""description"": ""Patent describing methods to stratify adolescent idiopathic scoliosis patients.""}, {""title"": ""Method of diagnosing adolescent idiopathic scoliosis"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""CHU Sainte-Justine"", ""description"": ""Patent for diagnostic methods of adolescent idiopathic scoliosis.""}, {""title"": ""Biomechanical-based methods of diagnosing scoliosis"", ""type"": ""Patent"", ""filing_year"": 2015, ""assignee"": ""CHU Sainte-Justine"", ""description"": ""Issued patent on biomechanical diagnostic methods for scoliosis.""}], ""level2_companies"": [{""company_name"": ""Inception Therapeutic Inc."", ""founding_year"": 2010, ""industry"": ""Biotechnology/Diagnostics"", ""connection"": ""Co-founded by Alain Moreau; develops diagnostic tests related to musculoskeletal disorders including osteoarthritis.""}]}"
"Arthur, Gilbert",University of Manitoba,Manitoba,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Preclinical development of glycerophosphocarbamates as prostate-selective anticancer drugs,137617,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; CANCER THERAPY GENERAL; CANCER; DRUG RESEARCH,7/1/2009,6/30/2010,1,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Labeled inhibitors of prostate specific membrane antigen (PSMA), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer"", ""type"": ""Patent"", ""filing_year"": 2013, ""assignee"": ""Not specified"", ""description"": ""Patent related to prostate cancer treatment involving labeled inhibitors of PSMA, filed after 2009-04.""}], ""level2_companies"": []}"
"Allard, Michael F",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Modulation of heart metabolism by hydrophobically modified hyperbranched polyglycerols,150000,0,1 yr 0 mth ,Circulatory and Respiratory Health,MYOCARDIAL INFARCTION; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CARDIOVASCULAR; DRUG RESEARCH,7/1/2009,6/30/2010,3,,"{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""HYPERBRANCHED POLYGLYCEROL FOR IMPROVING HEART FUNCTION"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""University of Toronto"", ""description"": ""Patent application including Michael F. Allard as inventor, related to modulation of heart metabolism by hydrophobically modified hyperbranched polyglycerols.""}, {""title"": ""Hyperbranched polyglycerol for improving heart function"", ""type"": ""European Patent EP2211872A1"", ""filing_year"": 2010, ""assignee"": ""University of Toronto"", ""description"": ""European patent published after 2009-04, related to improving heart function using hyperbranched polyglycerol, with Michael F. Allard as inventor.""}, {""title"": ""Derivatized hyperbranched polyglycerols for drug delivery"", ""type"": ""US Patent #9,561,278"", ""filing_year"": 2014, ""assignee"": ""University of Toronto"", ""description"": ""US patent filed and published after 2009, relevant to hydrophobically modified hyperbranched polyglycerols for drug delivery, with Michael F. Allard as inventor.""}], ""level2_companies"": []}"
"Powell, William S",McGill University,Quebec,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Development of novel OXE receptor antagonists for asthma,146000,0,1 yr 0 mth ,Circulatory and Respiratory Health,ASTHMA; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; RESPIRATION,7/1/2009,6/30/2010,2,,"{""primary_institute"": ""The Royal Institution for the Advancement of Learning/McGill University"", ""level1_ip"": [{""title"": ""5-oxo-ETE receptor antagonist compounds"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""The Royal Institution for the Advancement of Learning/McGill University"", ""description"": ""Novel pharmaceutically-useful compounds antagonizing the OXE receptor, relevant to asthma and eosinophilic diseases.""}, {""title"": ""OXE receptor antagonist compounds 230 and 264"", ""type"": ""Patent"", ""filing_year"": 2014, ""assignee"": ""Powell WS and Rokach J"", ""description"": ""Potent OXE receptor antagonists with potential therapeutic use in asthma, including compounds S-C025 and S-Y048.""}], ""level2_companies"": []}"
"Verma, Subodh S",Unity Health Toronto,Ontario,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Evaluation of BRCA1 as a Novel Therapeutic Strategy for Endothelial Dysfunction and Atherosclerosis,149998,0,1 yr 0 mth ,Circulatory and Respiratory Health,ATHEROSCLEROSIS; CARDIOVASCULAR,7/1/2009,6/30/2010,1,"GAP Solar Pvt Ltd, Satvika Infra India Private Limited, CardioLink clinical trial platform","{""primary_institute"": ""St. Michael's Hospital"", ""level1_ip"": [{""title"": ""Method for preventing and treating cardiovascular diseases with BRCA1"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""St. Michael's Hospital"", ""description"": ""Patent US8110185B2 filed on 2009-10-02 by St. Michael's Hospital with Subodh Verma as an assignor, directly relevant to BRCA1 as a therapeutic strategy for endothelial dysfunction and atherosclerosis.""}], ""level2_companies"": [{""company_name"": ""GAP Solar Pvt Ltd"", ""founding_year"": null, ""industry"": ""Solar Energy"", ""connection"": ""Founded by Subodh Verma, no direct link to BRCA1 research.""}, {""company_name"": ""Satvika Infra India Private Limited"", ""founding_year"": 2019, ""industry"": ""Infrastructure"", ""connection"": ""Founded by Subodh Verma, no direct link to BRCA1 research.""}, {""company_name"": ""CardioLink clinical trial platform"", ""founding_year"": 2015, ""industry"": ""Clinical Trials"", ""connection"": ""Founded by Subodh Verma, related to cardiac surgery clinical trials, no explicit commercialization of BRCA1 technology.""}]}"
"Cripton, Peter A",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Pro-Neck-Tor: A helmet to prevent spinal cord injuries occuring during sports and transportation,149752,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"INJURY, REGENERATION; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; NERVOUS SYSTEM",7/1/2009,6/30/2010,1,,"{""primary_institute"": ""University of British Columbia"", ""level1_ip"": [{""title"": ""APPARATUS FOR MITIGATING SPINAL CORD INJURY"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Peter Alec Cripton and Timothy Scott Nelson"", ""description"": ""A helmet with a movable inner shell designed to reduce neck injury by dissipating forces to the cervical spine, directly related to the Pro-Neck-Tor project.""}], ""level2_companies"": []}"
"Tessier, Philippe A",Universite Laval,Quebec,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Development of anti-S100 proteins for the treatment of arthritis,142600,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; CHRONIC INFLAMMATORY BOWEL DISEASE; IMMUNOLOGY-TRANSPLANTATION; MUSCLE, BONE, OR JOINT",7/1/2009,6/30/2010,3,,"{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Anti-S100A8 protein for treating leukemia"", ""type"": ""Patent"", ""filing_year"": 2016, ""assignee"": ""University of Toronto"", ""description"": ""Patent granted on January 19, 2021, for an anti-S100A8 protein, related to anti-S100 proteins for treatment purposes.""}, {""title"": ""Methods of treating rheumatoid arthritis using anti-S100A9 antibody"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""University of Toronto"", ""description"": ""US Patent US8282925B2 with priority date May 21, 2009, for treating rheumatoid arthritis using anti-S100A9 antibody.""}, {""title"": ""S100 protein inhibitors for treating leukemia"", ""type"": ""Patent Application"", ""filing_year"": 2015, ""assignee"": ""University of Toronto"", ""description"": ""US Patent Application US20150110774A1 filed August 25, 2015, for S100 protein inhibitors.""}], ""level2_companies"": []}"
"Hunter, Graeme K",Western University (Ontario),Ontario,Proof of Principle Program - Phase I,200904PPP,Proof of Principle,Crystal-binding peptides for prevention of kidney stone disease,116350,6000,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",GENITO/URINARY SYSTEM; ATHEROSCLEROSIS; DRUG RESEARCH; BIOPHYSICS,7/1/2009,6/30/2010,2,,"{""primary_institute"": ""University of Florida"", ""level1_ip"": [{""title"": ""Peptides for the treatment of renal disorders"", ""type"": ""Patent Application"", ""filing_year"": 2022, ""assignee"": ""University of Florida Research Foundation, Inc."", ""description"": ""Peptides that inhibit calcium oxalate crystallization to prevent kidney stone formation.""}, {""title"": ""Crystal-binding peptides for prevention of kidney stone disease"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""University of Florida Research Foundation, Inc."", ""description"": ""Peptides designed to bind to kidney stone crystals to prevent their growth and aggregation.""}], ""level2_companies"": []}"
"Powell, William S",McGill University,Quebec,Proof of Principle Program - Phase II,201309PP2,Proof of Principle,Development of novel OXE receptor antagonists for asthma,293133,0,1 yr 0 mth ,Circulatory and Respiratory Health,ASTHMA; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; RESPIRATION,7/1/2009,6/30/2010,2,,"{""primary_institute"": ""University of South Carolina"", ""level1_ip"": [{""title"": ""OXE receptor antagonists and related compounds"", ""type"": ""patent"", ""filing_year"": 2014, ""assignee"": ""Powell WS and Rokach J"", ""description"": ""Patent covering novel highly potent and metabolically resistant OXE receptor antagonists that block the actions of the granulocyte chemoattractant 5-oxo-ETE, relevant to asthma and eosinophilic diseases.""}, {""title"": ""Compounds S-C025 and S-Y048 as OXE receptor antagonists"", ""type"": ""patent"", ""filing_year"": 2015, ""assignee"": ""Powell WS and collaborators"", ""description"": ""Patents related to novel compounds S-C025 and S-Y048 acting as OXE receptor antagonists for therapeutic use in asthma.""}], ""level2_companies"": []}"
"Wasan, Kishor M",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,200810PP2,Proof of Principle,Development of a Novel Oral Amphotericin B Formulation for the Treatment of Systemic Fungal Infections,200000,0,1 yr 0 mth ,Infection and Immunity,null,1/1/2010,12/31/2009,2,iCo Therapeutics Inc.,"{""primary_institute"": ""University of British Columbia"", ""level1_ip"": [{""title"": ""Oral Amphotericin B Formulation"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""University of British Columbia"", ""description"": ""Lipid-based oral amphotericin B formulation for systemic fungal infections enhancing bioavailability and reducing toxicity.""}, {""title"": ""Lipid-Based Oral Formulation of Amphotericin B"", ""type"": ""Patent"", ""filing_year"": 2011, ""assignee"": ""University of British Columbia"", ""description"": ""Improved oral delivery system for amphotericin B targeting systemic fungal infections.""}], ""level2_companies"": [{""company_name"": ""iCo Therapeutics Inc."", ""founding_year"": 2008, ""industry"": ""Pharmaceuticals/Biotechnology"", ""connection"": ""Kishor M. Wasan is Director of Research and co-inventor of the oral amphotericin B technology commercialized by the company.""}]}"
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase II,200910PP2,Proof of Principle,Neuroprotection Rescue Strategies for Retinal Degeneration Diseases,250000,0,1 yr 0 mth ,Aging,DISEASES AFFECTING SPEECH/VISION/HEARING; AGING; VISION,4/1/2010,3/31/2011,3,"Trk Therapeutics Inc., Realist Pharma, Rayonnant Imaging Systems Inc.","{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Metabolic rescue of retinal degeneration"", ""type"": ""Patent WO2021062022A1"", ""filing_year"": 2020, ""assignee"": ""Not specified"", ""description"": ""Methods for treating retinal degeneration diseases with neuroprotective effects relevant to the project.""}, {""title"": ""Treatment and prevention of ocular neurodegenerative disorders including glaucoma"", ""type"": ""US Patent 11,389,439"", ""filing_year"": 2020, ""assignee"": ""Not specified"", ""description"": ""Neuroprotective pharmaceutical compositions for ocular neurodegenerative disorders.""}, {""title"": ""Neuroprotective compositions for retinal degeneration and related diseases"", ""type"": ""Patent application 20210299218"", ""filing_year"": 2021, ""assignee"": ""Not specified"", ""description"": ""Compositions and methods for neuroprotection in retinal degeneration.""}], ""level2_companies"": [{""company_name"": ""Trk Therapeutics Inc."", ""founding_year"": 2015, ""industry"": ""Biotechnology - Degenerative diseases including retinal degeneration"", ""connection"": ""Co-founder and Chief Scientific Officer: Saragovi, Horacio U""}, {""company_name"": ""Realist Pharma"", ""founding_year"": 2010, ""industry"": ""Biotechnology - Drug development"", ""connection"": ""Co-founder and former Chief Scientific Officer: Saragovi, Horacio U""}, {""company_name"": ""Rayonnant Imaging Systems Inc."", ""founding_year"": 2012, ""industry"": ""Imaging technology"", ""connection"": ""Director: Saragovi, Horacio U""}]}"
"Granville, David J",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,200910PP2,Proof of Principle,Therapeutic antibody development towards granzyme B,101240,0,1 yr 0 mth ,Circulatory and Respiratory Health,NONE OF THE ABOVE; AGING; CARDIOVASCULAR,4/1/2010,3/31/2011,4,"viDA Therapeutics, Inc., Radical Therapeutix Inc","{""primary_institute"": ""University of British Columbia (UBC)"", ""level1_ip"": [{""title"": ""Granzyme B inhibitor compositions, methods and uses for promoting wound healing"", ""type"": ""Patent"", ""filing_year"": 2011, ""assignee"": ""UBC"", ""description"": ""Patent US20140056964A1 filed in 2011 listing David J. Granville as inventor, covering granzyme B inhibitor compositions relevant to therapeutic antibody development.""}, {""title"": ""Granzyme B inhibitor compositions, methods and uses for promoting wound healing"", ""type"": ""Patent"", ""filing_year"": 2011, ""assignee"": ""UBC"", ""description"": ""WO Patent WO2012076985A2/A3 with priority date 2011-12-06, similar content and inventors including David J. Granville.""}, {""title"": ""Granzyme B inhibitor compositions, methods and uses for promoting wound healing"", ""type"": ""Patent"", ""filing_year"": 2011, ""assignee"": ""UBC"", ""description"": ""CA Patent CA2819810A1 with similar content listing David J. Granville.""}, {""title"": ""Granzyme B Directed Imaging and Therapy"", ""type"": ""Patent Application"", ""filing_year"": 2019, ""assignee"": ""UBC"", ""description"": ""US Patent Application 20190224348 issued 2019-07-25 involving antibodies binding granzyme B.""}], ""level2_companies"": [{""company_name"": ""viDA Therapeutics, Inc."", ""founding_year"": 2013, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by David J. Granville; commercializes granzyme B inhibitor technology derived from his research.""}, {""company_name"": ""Radical Therapeutix Inc"", ""founding_year"": 2015, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by David J. Granville; formed based on intellectual property where he is a primary inventor.""}]}"
"Huntsman, David G",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,A Diagnostic Test for Granulosa Cell Tumours of the Ovary,150000,0,1 yr 0 mth ,Cancer Research,CANCER,4/1/2010,3/31/2011,1,,"{""primary_institute"": ""University of British Columbia"", ""level1_ip"": [{""title"": ""Method for detecting granulosa cell tumors of the ovary"", ""type"": ""Patent Application"", ""filing_year"": 2011, ""assignee"": ""University of British Columbia"", ""description"": ""A diagnostic method detecting the FOXL2 402C>G mutation indicative of granulosa cell tumors of the ovary.""}], ""level2_companies"": []}"
"Jarzem, Peter F",McGill University,Quebec,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,"Minimally Invasive Ready, Highly Expandable Vertebral Body Replacement Device",122826,0,1 yr 0 mth ,Cancer Research,"BONE CANCER; MUSCULO SKELETAL; NERVOUS SYSTEM; MUSCLE, BONE, OR JOINT",4/1/2010,3/31/2011,4,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Minimally Invasive Expandable Contained Vertebral Implant and Method"", ""type"": ""Patent Application"", ""filing_year"": 2009, ""assignee"": ""Not specified"", ""description"": ""US Patent Application #20100268340 related to expandable vertebral body replacement devices, filed April 16, 2009, published October 21, 2010.""}, {""title"": ""Expandable Interbody Device for the Spine"", ""type"": ""Patent"", ""filing_year"": 2020, ""assignee"": ""Not specified"", ""description"": ""US Patent #10,874,524 issued December 29, 2020, relevant to minimally invasive vertebral body replacement.""}, {""title"": ""Minimally Invasive Expandable Vertebral Implant"", ""type"": ""Patent"", ""filing_year"": 2014, ""assignee"": ""Not specified"", ""description"": ""European Patent EP2419052B1 published July 9, 2014, related to minimally invasive expandable vertebral implants.""}, {""title"": ""Expandable Vertebral Body Replacement Device"", ""type"": ""Patent"", ""filing_year"": 2016, ""assignee"": ""Not specified"", ""description"": ""US Patent US9414867B2 issued after 2009, related to expandable vertebral body replacement devices.""}], ""level2_companies"": []}"
"Juncker, David",McGill University,Quebec,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Clinical validation of an innovative multiplex antibody microarray platform,150000,0,1 yr 0 mth ,Cancer Research,"MULTIDISCIPLINARY; BREAST CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; CANCER",4/1/2010,3/31/2011,3,Nomic,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Nanoarray-in-microarray assay system and method"", ""type"": ""Patent"", ""filing_year"": 2011, ""assignee"": ""David Juncker et al."", ""description"": ""A patent covering nanoarray-in-microarray assays relevant to multiplex antibody microarray platforms.""}, {""title"": ""Snap chip assembly for microarray reagent transfer"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""David Juncker et al."", ""description"": ""Patent describing a snap chip assembly facilitating reagent transfer in microarray systems.""}, {""title"": ""Microfluidic system for multiplex antibody microarrays"", ""type"": ""Patent"", ""filing_year"": 2013, ""assignee"": ""David Juncker et al."", ""description"": ""A microfluidic platform patent for multiplex antibody microarray applications.""}], ""level2_companies"": [{""company_name"": ""Nomic"", ""founding_year"": 2011, ""industry"": ""Biotechnology / Microarray Technology"", ""connection"": ""Co-founded by David Juncker; company founded after 2009-10; no direct evidence of licensing or commercialization of technology from the specified project.""}]}"
"Liu, Fei-Fei",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Targeting UROD As A Novel Anti-Cancer Therapeutic Strategy,150000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,4/1/2010,3/31/2011,1,World Labs,"{""primary_institute"": ""University Health Network"", ""level1_ip"": [{""title"": ""Utilization of UROD as a radio- and chemo-sensitizing target in human cancers"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""University Health Network"", ""description"": ""Patent application CA2010/000569 filed in 2010 covering the use of UROD targeting as a novel anti-cancer therapeutic strategy.""}], ""level2_companies"": [{""company_name"": ""World Labs"", ""founding_year"": 2024, ""industry"": ""Artificial Intelligence (Spatial Intelligence and Generative AI)"", ""connection"": ""Co-founded by Liu, Fei-Fei but unrelated to UROD anti-cancer therapeutic research""}]}"
"Poirier, Donald",Universite Laval,Quebec,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,L'evaluation du potentiel therapeutique in vivo d'une nouvelle famille d'aminosteroides comme agents anticancereux selectifs,149703,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,4/1/2010,3/31/2011,3,"Neolys Pharma, Trienix Pharma","{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Aminosteroid derivatives as anticancer agents"", ""type"": ""Patent"", ""filing_year"": 2019, ""assignee"": ""Donald Poirier"", ""description"": ""Patent covering aminosteroid derivatives for selective anticancer therapy, including US11174282B2 granted in the US.""}, {""title"": ""Aminosteroid derivatives as anticancer agents"", ""type"": ""Patent"", ""filing_year"": 2020, ""assignee"": ""Donald Poirier"", ""description"": ""European patent EP3464317A4 granted for aminosteroid derivatives targeting cancer cells.""}, {""title"": ""Aminosteroid derivatives as anticancer agents"", ""type"": ""Patent Application"", ""filing_year"": 2021, ""assignee"": ""Donald Poirier"", ""description"": ""Canadian patent application CA3024351A1 pending for aminosteroid anticancer compounds.""}], ""level2_companies"": [{""company_name"": ""Neolys Pharma"", ""founding_year"": 2010, ""industry"": ""Biopharmaceuticals"", ""connection"": ""Co-founded by Donald Poirier; licenses and commercializes aminosteroid anticancer technology from the research.""}, {""company_name"": ""Trienix Pharma"", ""founding_year"": 2015, ""industry"": ""Biopharmaceuticals"", ""connection"": ""Co-founded by Donald Poirier; involved in development of aminosteroid derivatives for cancer treatment.""}]}"
"Roberge, Michel",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Evaluation of the anticancer activity of a new autophagy-inhibitory drug,142989,0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; LUNG CANCER THERAPY; CANCER; BIOCHEMISTRY,4/1/2010,3/31/2011,3,Centre for Drug Research and Development (CDRD) / AdMare BioInnovations,"{""primary_institute"": ""Centre for Drug Research and Development (CDRD), now AdMare BioInnovations"", ""level1_ip"": [{""title"": ""Substituted thioxanthenone autophagy inhibitors useful for cancer treatment"", ""type"": ""Patent"", ""filing_year"": 2016, ""assignee"": ""Michel Roberge et al."", ""description"": ""Patent covering novel substituted thioxanthenone compounds that inhibit autophagy and show anticancer activity.""}, {""title"": ""Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy"", ""type"": ""Patent Application"", ""filing_year"": 2017, ""assignee"": ""Michel Roberge et al."", ""description"": ""Patent application for dimeric quinacrine derivatives designed to inhibit autophagy in cancer cells.""}, {""title"": ""Benzothiophene compounds as alternative autophagy inhibitors with anticancer activity"", ""type"": ""Patent"", ""filing_year"": 2019, ""assignee"": ""Michel Roberge et al."", ""description"": ""Patent on benzothiophene-based compounds that act as autophagy inhibitors with potential anticancer effects.""}], ""level2_companies"": [{""company_name"": ""Centre for Drug Research and Development (CDRD) / AdMare BioInnovations"", ""founding_year"": 2007, ""industry"": ""Drug Discovery and Development"", ""connection"": ""Co-founded by Michel Roberge; involved in drug discovery including cancer therapeutics relevant to autophagy inhibition.""}]}"
"Sadar, Marianne D",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Preclinical evaluation of sintokamides as agents for treatment of advanced prostate cancer,150000,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; PROSTATE AND BLADDER CANCER THERAPY; CANCER; ENDOCRINOLOGY,4/1/2010,3/31/2011,2,ESSA Pharma Inc.,"{""primary_institute"": ""University of British Columbia"", ""level1_ip"": [{""title"": ""Compounds and methods for modulating androgen receptor activity"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""University of British Columbia"", ""description"": ""Pharmaceutical compositions and methods targeting the androgen receptor N-terminal domain for treatment of advanced prostate cancer, including sintokamide derivatives.""}, {""title"": ""Small molecule inhibitors of androgen receptor N-terminal domain"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""University of British Columbia"", ""description"": ""Novel small molecules that inhibit androgen receptor activity by binding to the N-terminal domain, useful in treating advanced prostate cancer.""}], ""level2_companies"": [{""company_name"": ""ESSA Pharma Inc."", ""founding_year"": 2009, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by Marianne D. Sadar; company licenses and commercializes technology related to androgen receptor inhibitors for advanced prostate cancer treatment, directly linked to sintokamide research.""}]}"
"Weinfeld, Michael",University of Alberta,Alberta,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Small molecule inhibitor of polynucleotide kinase/phosphatase and uses thereof in cancer treatment.,150000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,4/1/2010,3/31/2011,2,Onco-Innovations Limited,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Imidopiperidine Compounds as Inhibitors of Human Polynucleotide Kinase Phosphatase"", ""type"": ""Patent"", ""filing_year"": 2018, ""assignee"": ""Michael Weinfeld"", ""description"": ""Patent describing imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphatase relevant to cancer treatment.""}, {""title"": ""PNKP Inhibitors and Their Use as Chemosensitizers/Radiosensitizers"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""Michael Weinfeld"", ""description"": ""Patents and patent applications related to polynucleotide kinase phosphatase inhibitors for enhancing cancer therapy.""}], ""level2_companies"": [{""company_name"": ""Onco-Innovations Limited"", ""founding_year"": 2024, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Licensed technology related to PNKP inhibitors for cancer treatment derived from Michael Weinfeld's research; Michael Weinfeld is not a founder or co-founder.""}]}"
"Yang, Victor X",Toronto Metropolitan University,Ontario,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Doppler Optical Coherence Tomography for Intraoperative Imaging During Skull Base Neurosurgical Procedures,149984,0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; IMAGING; BIOPHYSICS,4/1/2010,3/31/2011,2,7D Surgical,"{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Optical Coherence Tomography Device with Motion Contrast Data Processing"", ""type"": ""Patent"", ""filing_year"": 2016, ""assignee"": ""Victor X. D. Yang"", ""description"": ""A device and method for optical coherence tomography incorporating Doppler imaging and motion contrast to enhance intraoperative imaging capabilities.""}, {""title"": ""Doppler Optical Coherence Tomography Imaging System and Method"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""Victor X. D. Yang"", ""description"": ""Systems and methods for Doppler OCT imaging designed for real-time intraoperative use in neurosurgical procedures.""}], ""level2_companies"": [{""company_name"": ""7D Surgical"", ""founding_year"": 2010, ""industry"": ""Medical Imaging Technology"", ""connection"": ""Co-founded by Victor X. Yang; commercializes Doppler OCT technology for intraoperative neurosurgical imaging.""}]}"
"Crystal, Eugene","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Three-dimensional Catheter Tracking using a Single Two-dimensional Image,130077,12873,1 yr 0 mth ,Circulatory and Respiratory Health,CARDIOLOGY; ARRHYTHMIAS; IMAGING; CARDIOVASCULAR,4/1/2010,3/31/2011,2,,"{""primary_institute"": ""Sunnybrook Health Sciences Centre"", ""level1_ip"": [{""title"": ""Method and system for three-dimensional catheter tracking using a single two-dimensional image"", ""type"": ""Patent Application"", ""filing_year"": 2013, ""assignee"": ""Sunnybrook Health Sciences Centre"", ""description"": ""A method for determining the three-dimensional location of an interventional medical device such as a catheter in real-time from a single two-dimensional medical image.""}, {""title"": ""Three-dimensional display and signal acquisition from multi-electrode catheters"", ""type"": ""Patent Application"", ""filing_year"": 2022, ""assignee"": ""Biosense Webster Israel Ltd"", ""description"": ""Techniques related to three-dimensional visualization and signal processing of multi-electrode catheters for cardiac mapping.""}], ""level2_companies"": []}"
"Boivin, Guy",Universite Laval,Quebec,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,New antiviral agents against herpes simplex viruses,150000,0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; VIROLOGY; DRUG RESEARCH,4/1/2010,3/31/2011,0,"Vaxxel, Signia Therapeutics","{""primary_institute"": ""Not specified"", ""level1_ip"": [], ""level2_companies"": [{""company_name"": ""Vaxxel"", ""founding_year"": 2012, ""industry"": ""Antiviral Research"", ""connection"": ""Co-founded by Boivin, Guy, involved in antiviral research relevant to herpes simplex viruses""}, {""company_name"": ""Signia Therapeutics"", ""founding_year"": 2015, ""industry"": ""Drug Repositioning for Viral Respiratory Infections"", ""connection"": ""Co-founded by Boivin, Guy, specializing in antiviral drug development""}]}"
"Withers, Stephen G",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Novel mechanism-based inhibitors of influenza neuraminidase as potential anti-viral agents,150000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; VIRAL; VIROLOGY; POPULATION HEALTH,4/1/2010,3/31/2011,3,,"{""primary_institute"": ""University of British Columbia"", ""level1_ip"": [{""title"": ""Mechanism-based covalent inhibitors of influenza neuraminidase"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Stephen G. Withers / University of British Columbia"", ""description"": ""Compounds designed as mechanism-based inhibitors targeting influenza neuraminidase enzyme to act as potential antiviral agents.""}, {""title"": ""Equatorial 2,3-fluorinated glycosides as neuraminidase inhibitors"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""Stephen G. Withers / University of British Columbia"", ""description"": ""Fluorinated glycoside compounds developed to inhibit influenza neuraminidase activity, serving as antiviral therapeutics.""}, {""title"": ""Use of TR1 as an active site titrant for influenza neuraminidase"", ""type"": ""Patent Application"", ""filing_year"": 2011, ""assignee"": ""Stephen G. Withers / University of British Columbia"", ""description"": ""Development and application of TR1 compound to titrate active sites of influenza neuraminidase enzyme for inhibitor design.""}], ""level2_companies"": []}"
"Philip, Anie",Research Institute of the McGill University Health Centre,Quebec,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Identification of a low molecular weight peptide of CD109 as an anti-scarring agent,150000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,MUSCULO SKELETAL; CANCER THERAPY GENERAL; MOLECULAR BIOLOGY; CELL BIOLOGY,4/1/2010,3/31/2011,1,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Cd109 polypeptides and uses thereof for the treatment of skin cells"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Not specified"", ""description"": ""Compounds and methods for treating skin disorders including fibrosis and scarring using CD109 polypeptides, directly related to the research on CD109 peptides as anti-scarring agents.""}], ""level2_companies"": []}"
"Waldman, Stephen D","Queen's University (Kingston, Ontario)",Ontario,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Tissue engineered cartilage suitable for the repair of clinically-relevant sized defects,148139,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"INJURY, REGENERATION; ARTHRITIS/OSTEOARTHRITIS; MUSCLE, BONE, OR JOINT; BIOPHYSICS",4/1/2010,3/31/2011,2,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same"", ""type"": ""Patent Application"", ""filing_year"": 2012, ""assignee"": ""Stephen D. Waldman or affiliated institution"", ""description"": ""A patent application filed in 2012 related to tissue engineered cartilage suitable for repair of clinically relevant sized defects.""}, {""title"": ""Methods for improving cartilage tissue formation"", ""type"": ""Patent Application"", ""filing_year"": 2018, ""assignee"": ""Stephen D. Waldman or affiliated institution"", ""description"": ""A patent application filed in 2018 describing methods to enhance cartilage tissue formation, relevant to tissue engineering cartilage.""}], ""level2_companies"": []}"
"Liu, Fang",Centre for Addiction and Mental Health (Toronto),Ontario,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Therapeutics targeting receptor-receptor interactions for Addiction,150000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUG RESEARCH; MENTAL HEALTH,4/1/2010,3/31/2011,1,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Method and composition related to combination therapy for addiction"", ""type"": ""Patent"", ""filing_year"": 2020, ""assignee"": ""Liu, Fang et al."", ""description"": ""Methods of treating addictive behavior by targeting receptor interactions relevant to addiction, specifically using a combination of 5-HT2C receptor agonist and DA D3/D4 receptor antagonist.""}], ""level2_companies"": []}"
"Weaver, Donald F",IWK Health Centre (Halifax),Nova Scotia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Contact Optical Microscopy,148684,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; MULTIDISCIPLINARY; IMAGING; INTERNATIONAL HEALTH,4/1/2010,3/31/2011,2,"Neurochem Inc., Treventis Corp., Molecular Mining Corp., DeNovaMed Inc., Mindful Scientific Inc.","{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Optical microscope apparatus"", ""type"": ""Patent"", ""filing_year"": 2009, ""assignee"": ""University of Toronto"", ""description"": ""An optical microscope apparatus improving imaging capabilities, filed shortly after 2009-10.""}, {""title"": ""Microscopy imaging system and methods"", ""type"": ""Patent Application"", ""filing_year"": 2023, ""assignee"": ""University of Toronto"", ""description"": ""Advanced microscopy imaging system including fluorescence lifetime imaging and scanning light microscopy techniques.""}], ""level2_companies"": [{""company_name"": ""Neurochem Inc."", ""founding_year"": 2000, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by Donald F Weaver""}, {""company_name"": ""Treventis Corp."", ""founding_year"": 2005, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by Donald F Weaver""}, {""company_name"": ""Molecular Mining Corp."", ""founding_year"": 2007, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by Donald F Weaver""}, {""company_name"": ""DeNovaMed Inc."", ""founding_year"": 2010, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Co-founded by Donald F Weaver""}, {""company_name"": ""Mindful Scientific Inc."", ""founding_year"": 2013, ""industry"": ""Medical Devices/Neuroscience"", ""connection"": ""Co-founded by Donald F Weaver""}]}"
"Weaver, Donald F",IWK Health Centre (Halifax),Nova Scotia,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Pharmacokinetic Optimization of a New Drug for Alzheimer's Disease,150000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",ALZHEIMER'S DISEASE; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; NERVOUS SYSTEM,4/1/2010,3/31/2011,1,"Neurochem Inc., Treventis Corp.","{""primary_institute"": ""University of Toronto"", ""level1_ip"": [{""title"": ""Treatment of protein folding disorders including Alzheimer's disease"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""Donald F. Weaver"", ""description"": ""Patent covering compounds and methods for treating protein folding disorders such as Alzheimer's disease, filed after October 2009.""}], ""level2_companies"": [{""company_name"": ""Neurochem Inc."", ""founding_year"": 2000, ""industry"": ""Biotechnology - Alzheimer's therapeutics"", ""connection"": ""Co-founded by Donald F. Weaver; advanced Alzheimer's drug candidates to Phase III trials and IPO on TSX and NASDAQ; commercialized technology related to Weaver's research.""}, {""company_name"": ""Treventis Corp."", ""founding_year"": 2010, ""industry"": ""Biotechnology - Small molecule therapeutics for Alzheimer's"", ""connection"": ""Co-founded by Donald F. Weaver; developing tau-targeting therapeutics for Alzheimer's; licensed technology from Weaver's research; collaboration with Takeda Inc.""}]}"
"Rogers, Ian M",Sinai Health System (Toronto),Ontario,Proof of Principle Program - Phase I,200910PPP,Proof of Principle,Cell therapy for the treatment of type 1 Diabetes,150000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM/DIABETES,4/1/2010,3/31/2011,0,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [], ""level2_companies"": []}"
"Tremblay, Michel L",McGill University,Quebec,Proof of Principle Program Phase I - Drug Development,201003PDD,Proof of Principle,Discovery and uses of a new class of small molecule inhibitors of tyrosine phosphatases.,158850,0,1 yr 0 mth ,Cancer Research,MULTIPLE DISEASE RELEVANCE; BREAST CANCER THERAPY; BIOCHEMISTRY; DRUG RESEARCH,10/1/2010,9/30/2011,null,null,null
"Wu, Jian Hui",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program Phase I - Drug Development,201003PDD,Proof of Principle,Novel bifunctional antiandrogens that suppress oncogenic activation of the androgen receptor in castration-resistant prostate cancer,159750,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; CANCER; ENDOCRINOLOGY,10/1/2010,9/30/2011,2,OncoThera Biotech,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""Bifunctional Antiandrogens for Castration-Resistant Prostate Cancer"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""University of California"", ""description"": ""Patent covering novel bifunctional antiandrogens that inhibit androgen receptor activation in castration-resistant prostate cancer, filed by Wu, Jian Hui and collaborators.""}, {""title"": ""Methods and Compositions for Treating Prostate Cancer"", ""type"": ""Patent"", ""filing_year"": 2015, ""assignee"": ""University of California"", ""description"": ""Patent describing compositions and methods using bifunctional antiandrogens targeting androgen receptor pathways in prostate cancer, with Wu, Jian Hui as inventor.""}], ""level2_companies"": [{""company_name"": ""OncoThera Biotech"", ""founding_year"": 2014, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Founded by Wu, Jian Hui to develop and commercialize bifunctional antiandrogen therapies for castration-resistant prostate cancer.""}]}"
"Doschak, Michael R",University of Alberta,Alberta,Proof of Principle Program Phase I - Drug Development,201003PDD,Proof of Principle,Bisphosphonate-conjugated Calcitonin,117929,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MUSCULO SKELETAL; DRUG RESEARCH; MUSCLE, BONE, OR JOINT",10/1/2010,9/30/2011,null,null,null
"Chemtob, Sylvain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Proof of Principle Program - Phase II,201003PP2,Proof of Principle,IL-1  Allosteramers to treat diabetes and its complications,300000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; METABOLISM/DIABETES; VISION,10/1/2010,9/30/2011,3,Allostera Pharma,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""IL-1 receptor modulation by Allosteramers"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Chemtob, Sylvain et al."", ""description"": ""Patent application US20100041609A1 related to IL-1 receptor modulation by Allosteramers.""}, {""title"": ""Azapeptides as CD36 binding compounds"", ""type"": ""Granted Patent"", ""filing_year"": 2019, ""assignee"": ""Chemtob, Sylvain et al."", ""description"": ""US Patent 9,708,370 covering azapeptides as CD36 binding compounds relevant to diabetes treatment.""}, {""title"": ""Improved Allosteramers for modulating IL-1 receptor activity"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Chemtob, Sylvain et al."", ""description"": ""WO2010106441A3 on Allosteramers targeting IL-1 receptor activity.""}], ""level2_companies"": [{""company_name"": ""Allostera Pharma"", ""founding_year"": 2006, ""industry"": ""Biotechnology/Pharmaceuticals"", ""connection"": ""Founded by Sylvain Chemtob; develops Allosteramers for inflammation and autoimmunity including diabetes-related targets.""}]}"
"Brown, Jeremy A",Dalhousie University (Nova Scotia),Nova Scotia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,A High-Resolution Ultrasonic Endoscope for the Auditory System,108000,10600,1 yr 0 mth ,Aging,DEAFNESS; DISEASES AFFECTING SPEECH/VISION/HEARING; IMAGING; HEARING,10/1/2010,9/30/2011,4,,"{""primary_institute"": ""Dalhousie University"", ""level1_ip"": [{""title"": ""Ultrasonic endoscope with heat dissipation structure in the distal end portion"", ""type"": ""Patent Application"", ""filing_year"": 2017, ""assignee"": ""Jeremy A. Brown"", ""description"": ""Patent application for an ultrasonic endoscope featuring a heat dissipation structure at the distal end to improve device performance and safety.""}, {""title"": ""Ultrasound element and ultrasound endoscope with specific electrode and insulating layer structures"", ""type"": ""Patent Application"", ""filing_year"": 2014, ""assignee"": ""Jeremy A. Brown"", ""description"": ""Patent application describing ultrasound elements and endoscopes with novel electrode and insulating layer configurations enhancing imaging quality.""}, {""title"": ""Ultrasound endoscope and methods of manufacture, including phased array transducers suitable for endoscopes"", ""type"": ""Patent Application"", ""filing_year"": 2013, ""assignee"": ""Jeremy A. Brown"", ""description"": ""International patent application covering ultrasound endoscope designs and manufacturing methods utilizing phased array transducers.""}, {""title"": ""Ultrasound scanning capsule endoscope (USCE) with phased array acoustic transducers"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""Jeremy A. Brown"", ""description"": ""Granted patent for a capsule endoscope employing phased array acoustic transducers for ultrasound scanning.""}], ""level2_companies"": []}"
"Lam, Stephen",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,CTAP III for detection of early lung cancer and monitoring treatment outcome,160000,0,1 yr 0 mth ,Cancer Research,LUNG CANCER; CANCER,10/1/2010,9/30/2011,null,null,null
"Mes-Masson, Anne-Marie",Centre hospitalier de l'Universite de Montreal (CHUM),Quebec,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Development and validation of a multiplex blood-based assay for the early detection of ovarian cancer.,160000,0,1 yr 0 mth ,Cancer Research,GENITO/URINARY SYSTEM; NEOPLASMS; CANCER; HEALTH RESEARCH,10/1/2010,9/30/2011,2,,"{""primary_institute"": ""Institut du Cancer de Montr\u00e9al"", ""level1_ip"": [{""title"": ""Multiplex assay for early detection of ovarian cancer"", ""type"": ""Patent"", ""filing_year"": 2012, ""assignee"": ""Institut du Cancer de Montr\u00e9al"", ""description"": ""A multiplex blood-based assay designed for the early detection of ovarian cancer, improving diagnostic accuracy.""}, {""title"": ""Biomarker panel for ovarian cancer diagnosis"", ""type"": ""Patent"", ""filing_year"": 2014, ""assignee"": ""Institut du Cancer de Montr\u00e9al"", ""description"": ""A panel of biomarkers identified and validated for use in a blood test to detect ovarian cancer at early stages.""}], ""level2_companies"": []}"
"Webb, John R",University of Victoria (British Columbia),British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Pre-clinical development of Pentarix: a therapeutic vaccine for HPV-associated cancers,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; VIRAL; CANCER; IMMUNOLOGY-TRANSPLANTATION,10/1/2010,9/30/2011,null,null,null
"Andersen, Raymond J",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,"Latonduine A, A Potent delF508-CFTR Trafficking Defect Corrector With Potential for Treating Cystic Fibrosis",159750,0,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; INFECTIOUS AND PARASITIC; DRUG RESEARCH,10/1/2010,9/30/2011,null,null,null
"Cunningham, Charles H","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Wire for MRI-Guided Interventions,139840,8395,1 yr 0 mth ,Circulatory and Respiratory Health,CORONARY CIRCULATION (INCL. INSUFFICIENCY); IMAGING; CARDIOVASCULAR,10/1/2010,9/30/2011,null,null,null
"Kouassi, Edouard",CIUSSS Est-de-l'Ile-de- Montreal-Maisonneuve Rosemont,Quebec,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Novel methods and compounds for increasing red blood cell survival,160000,0,1 yr 0 mth ,Circulatory and Respiratory Health,BLOOD; ANAEMIAS; DRUG RESEARCH,10/1/2010,9/30/2011,2,,"{""primary_institute"": ""Not specified"", ""level1_ip"": [{""title"": ""METHODS AND COMPOUNDS FOR INCREASING RED BLOOD CELL SURVIVAL"", ""type"": ""Patent Application"", ""filing_year"": 2010, ""assignee"": ""Edouard Kouassi"", ""description"": ""Methods and compositions for increasing red blood cell survival and/or inhibiting hemolysis using indole-comprising compounds.""}, {""title"": ""Method for enhancing red blood cell quality and survival during storage"", ""type"": ""Patent"", ""filing_year"": 2010, ""assignee"": ""Edouard Kouassi"", ""description"": ""Enhancing red blood cell quality and survival by depleting carbon dioxide and oxygen and maintaining 2,3-diphosphoglycerate acid levels.""}], ""level2_companies"": []}"
"Lerouge, Sophie",ecole de technologie superieure (Montreal),Quebec,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,A new therapeutic agent for the treatment and prevention of endoleaks after endovascular aneurysm repair,155000,0,1 yr 0 mth ,Circulatory and Respiratory Health,ATHEROSCLEROSIS; CARDIOVASCULAR,10/1/2010,9/30/2011,null,null,null
"McNagny, Kelly M",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,CD34 as a therapeutic target for allergic asthma,160000,0,1 yr 0 mth ,Infection and Immunity,ASTHMA; RESPIRATION; IMMUNOLOGY-TRANSPLANTATION,10/1/2010,9/30/2011,null,null,null
"Alman, Benjamin A",Hospital for Sick Children (Toronto),Ontario,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Nefopam as an agent to prevent and treat hyperplastic scars,159975,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; DRUG RESEARCH",10/1/2010,9/30/2011,null,null,null
"Shoichet, Molly S",University of Toronto,Ontario,Proof of Principle Program - Phase I,201003PPP,Proof of Principle,Commercial Development of Bioengineered Therapeutic Strategy for Spinal Cord Injury,159996,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",SPINAL CORD DISEASE; NERVOUS SYSTEM,10/1/2010,9/30/2011,null,null,null
"Zeng, Haishan",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201009PP2,Proof of Principle,Development of a laser Raman spectroscopy system for melanoma detection,244071,48211,1 yr 0 mth ,Cancer Research,MULTIDISCIPLINARY; SKIN AND SUBCUTANEOUS TISSUS; CANCER; IMAGING,4/1/2011,3/31/2012,null,null,null
"Dmitrienko, Gary I",University of Waterloo (Ontario),Ontario,Proof of Principle Program - Phase II,201009PP2,Proof of Principle,New drugs for antibiotic resistant bacterial infections,133277,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUG RESEARCH; BIOCHEMISTRY,4/1/2011,3/31/2012,null,null,null
"Finlay, Barton B",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201009PP2,Proof of Principle,A sub-unit based vaccine for Salmonella,149685,0,1 yr 0 mth ,Infection and Immunity,GASTRO-INTESTINAL DISEASE; INFECTIOUS AND PARASITIC; BACTERIOLOGY; GASTROINTESTINAL (LIVER),4/1/2011,3/31/2012,null,null,null
"Chopra, Rajiv","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Development of endorectal MR elastography for prostate cancer detection,153344,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; IMAGING; CANCER,4/1/2011,3/31/2012,null,null,null
"Houde, Daniel",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Radiotherapie par filamentation laser femtoseconde,112602,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BRAIN TUMORS THERAPY; CANCER; BIOPHYSICS,4/1/2011,3/31/2012,null,null,null
"Meloche, Sylvain",Universite de Montreal,Quebec,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Targeting the degradation of the cyclin-dependent kinase inhibitor p21 as a novel approach to cancer therapy,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,4/1/2011,3/31/2012,null,null,null
"Nepveu, Alain",McGill University,Quebec,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Validation of the CUX1 Expression Signature as an RT-PCR-Based Prognostic Tool,159950,0,1 yr 0 mth ,Cancer Research,BREAST CANCER; NEOPLASMS; CANCER; MOLECULAR BIOLOGY,4/1/2011,3/31/2012,null,null,null
"Petrecca, Kevin",McGill University,Quebec,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Identification of Novel Compounds Inhibiting Brain Cancer Invasion,120775,0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; NEOPLASMS; CANCER; DRUG RESEARCH,4/1/2011,3/31/2012,null,null,null
"Schimmer, Aaron D",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Repositioning tigecycline for the treatment of leukemia,156750,0,1 yr 0 mth ,Cancer Research,LEUKAEMIAS; CANCER THERAPY GENERAL; CANCER; CELL BIOLOGY,4/1/2011,3/31/2012,null,null,null
"Rogers, Ian M",Sinai Health System (Toronto),Ontario,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,The Use of Multipotential Stem Cells for the Treatment of Peripheral Vascular Disease,160000,0,1 yr 0 mth ,Circulatory and Respiratory Health,NONE OF THE ABOVE; CORONARY CIRCULATION (INCL. INSUFFICIENCY); NOT CLASSIFIED; CARDIOVASCULAR,4/1/2011,3/31/2012,null,null,null
"Jarvi, Keith A",Sinai Health System (Toronto),Ontario,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,"Novel semen biomarkers to identify sperm production in men with infertility: A non-invasive method to characterize men with azoospermia or no sperm in the semen, into those with and without testicular sperm production",152499,0,1 yr 0 mth ,"Human Development, Child and Youth Health",INFERTILITY MALE; GENITO/URINARY SYSTEM; ENDOCRINOLOGY; REPRODUCTION/PREGNANCY,4/1/2011,3/31/2012,null,null,null
"Bell, John C",Ottawa Hospital Research Institute,Ontario,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Increasing vaccine manufacturing output using viral sensitizer technology,136750,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; VIRAL; HEALTH RESEARCH; VIROLOGY,4/1/2011,3/31/2012,null,null,null
"Booth, Valerie K",Memorial University of Newfoundland,Newfoundland and Labrador,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,HLA Peptide Development as a Therapeutic for Psoriasis,156920,0,1 yr 0 mth ,Infection and Immunity,SKIN AND SUBCUTANEOUS TISSUS; BIOCHEMISTRY; DRUG RESEARCH,4/1/2011,3/31/2012,null,null,null
"Schrader, John W",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Preclinical evaluation of a truly human monoclonal antibody for the therapy of infections with a broad spectrum of influenza viruses,160000,0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; IMMUNOLOGY-TRANSPLANTATION; DRUG RESEARCH,4/1/2011,3/31/2012,null,null,null
"Gratzer, Paul F",Dalhousie University (Nova Scotia),Nova Scotia,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Decellularization of Human Skin,149034,10900,1 yr 0 mth ,Musculoskeletal Health and Arthritis,SKIN AND SUBCUTANEOUS TISSUS; IMMUNOLOGY-TRANSPLANTATION; NOT CLASSIFIED,4/1/2011,3/31/2012,null,null,null
"Grynpas, Marc D",Sinai Health System (Toronto),Ontario,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,"""Calcium Polyphosphate Bone Substitutes""",156022,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"OSTEOPOROSIS; AGING; MUSCLE, BONE, OR JOINT",4/1/2011,3/31/2012,null,null,null
"Martineau, Paul A",Research Institute of the McGill University Health Centre,Quebec,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,POROUS COMPRESSION SCREW for FRACTURE FIXATION,155375,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"INJURY, REGENERATION; HEALTH CARE DELIVERY; HEALTH RESEARCH; MUSCLE, BONE, OR JOINT",4/1/2011,3/31/2012,null,null,null
"Moreau, Alain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Methods of Diagnosing Primary Osteoarthritis,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; CELL BIOLOGY",4/1/2011,3/31/2012,null,null,null
"Underhill, Michael",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201009PPP,Proof of Principle,Novel Applications of Potassium Channel Blockers in Arthritis,146400,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT; AGING",4/1/2011,3/31/2012,null,null,null
"Hancock, Robert Ernest W",University of British Columbia,British Columbia,Proof of Principle Program Phase I - Drug Development,201102PDD,Proof of Principle,Novel anti-inflammatory treatment for Amyotrophic Lateral Sclerosis,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; AMYOTROPHIC LATERAL SCLEROSIS (ALS); DRUG RESEARCH; NERVOUS SYSTEM,10/1/2011,9/30/2012,null,null,null
"Sipione, Simonetta",University of Alberta,Alberta,Proof of Principle Program Phase I - Drug Development,201102PDD,Proof of Principle,Development of ganglioside-based therapies for Huntington's disease,159196,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",HUNTINGTON'S DISEASE; MULTIPLE DISEASE RELEVANCE; NERVOUS SYSTEM; CELL BIOLOGY,10/1/2011,9/30/2012,null,null,null
"Riddell, Michael C","York University (Toronto, Ontario)",Ontario,Proof of Principle Program Phase I - Drug Development,201102PDD,Proof of Principle,Pharmaceutical intervention to decrease the threat of hypoglycemia in insulin-treated diabetics,160000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; ENDOCRINOLOGY; METABOLISM/DIABETES,10/1/2011,9/30/2012,null,null,null
"Chopra, Rajiv","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase II,201102PP2,Proof of Principle,Evaluation of MRI-controlled interstitial ultrasound therapy for the treatment of cerebral neoplasms,147500,0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; IMAGING; CANCER,10/1/2011,9/30/2012,null,null,null
"Sadar, Marianne D",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201102PP2,Proof of Principle,Translational Development Program For Analogues of EPI-001 (PNG01-185) Compounds For the Treatment of Advanced Prostate Cancer,300000,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; CANCER; DRUG RESEARCH,10/1/2011,9/30/2012,null,null,null
"Alaoui-Jamali, Moulay A",McGill University,Quebec,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Triple Targeted Kinase Inhibitors Capable of Inhibiting Breast Cancer Metastases,160000,0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; BREAST CANCER; CANCER; DRUG RESEARCH,10/1/2011,9/30/2012,null,null,null
"Boerkoel, Cornelius F",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Development of Tdp1 inhibitors for treating cancer,159927,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,10/1/2011,9/30/2012,null,null,null
"C.-Gaudreault, Rene",Universite Laval,Quebec,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Optimization and Validation of Highly Cytocidal Substituted Phenyl Imidazolidin-2-one as Antimicrotubule Agents for Cancer Chemotherapy,160000,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,10/1/2011,9/30/2012,null,null,null
"Dacosta, Ralph S",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,"Development of PRODIGI, a Handheld Optical Imaging Technology for Real-time Intraoperative-guidance of Breast Tumour Resection",121250,24000,1 yr 0 mth ,Cancer Research,BREAST CANCER; BREAST CANCER THERAPY; IMAGING; CANCER,10/1/2011,9/30/2012,null,null,null
"Pelletier, Jerry M",McGill University,Quebec,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Chemotherapeutic Agents for Inhibiting Protein Synthesis,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,10/1/2011,9/30/2012,null,null,null
"Yudin, Andrei",University of Toronto,Ontario,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Arrays of constrained histone tail mimetics for the development of epigenetic anticancer drugs,85712,74288,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,10/1/2011,9/30/2012,null,null,null
"Frost, Eric H",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,"Simultaneous Influenza A detection, subtyping, and oseltamivir resistance determination",95000,65000,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; MULTIPLE DISEASE RELEVANCE; VIROLOGY; HEALTH RESEARCH,10/1/2011,9/30/2012,null,null,null
"Graham, Simon J","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Tablet Technology for Assessing Dementia,116402,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",ALZHEIMER'S DISEASE; IMAGING; NERVOUS SYSTEM,10/1/2011,9/30/2012,null,null,null
"Mishra, Ram K",McMaster University,Ontario,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,A novel dopamine D2 receptor allosteric modulator: Development and commercialization of a safer more effective generation of antipsychotic drugs,146850,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",SCHIZOPHRENIA; PARKINSON'S DISEASE; MENTAL HEALTH; BIOCHEMISTRY,10/1/2011,9/30/2012,null,null,null
"Prentki, Marc",Centre hospitalier de l'Universite de Montreal (CHUM),Quebec,Proof of Principle Program - Phase I,201102PPP,Proof of Principle,Validation of a glycerolipid/ free fatty acid cycling enzyme as a novel therapeutic target for type-2 diabetes,157925,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; METABOLISM AND NUTRITION; METABOLISM/DIABETES; DRUG RESEARCH,10/1/2011,9/30/2012,null,null,null
"Schweizer, Frank",University of Manitoba,Manitoba,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Optimization and preclinical studies on amphiphilic aminoglycoside antimicrobials (AAAs),160000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; HEALTH RESEARCH; DRUG RESEARCH,4/1/2012,3/31/2013,,,
"Chan, Tak Hang",McGill University,Quebec,Proof of Principle Program - Phase II,201109PP2,Proof of Principle,Evaluation of novel flavonoids in models of hematological cancer,300000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; NEOPLASMS; DRUG RESEARCH; CANCER,4/1/2012,3/31/2013,null,null,null
"Burt, Helen M",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Intravesical Taxanes,157412,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; DRUG RESEARCH,4/1/2012,3/31/2013,null,null,null
"Gobeil, Fernand J",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Agonistes synthetiques de kinines : Optimiser la livraison et l'efficacite des chimiotherapies des tumeurs cerebrales,149418,0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; BRAIN TUMORS (INCL. RETINAL TUMORS); CANCER; HEALTH RESEARCH,4/1/2012,3/31/2013,null,null,null
"Hassell, John A",McMaster University,Ontario,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Characterization of small molecule sensitizers to chemotherapy,160000,0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; BREAST CANCER; CANCER; DRUG RESEARCH,4/1/2012,3/31/2013,null,null,null
"Kelley, Shana O",University of Toronto,Ontario,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Preclinical testing of a mitochondrially-targeted anticancer agent,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER; GENETICS,4/1/2012,3/31/2013,null,null,null
"Kubow, Stanley",McGill University,Quebec,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Protective Effects of Potato Polyphenol-Rich Extracts Against Lung Damage Caused by Air Pollutants,150525,0,1 yr 0 mth ,Circulatory and Respiratory Health,ENVIRONMENTAL INFLUENCES ON HEALTH; RESPIRATION; NUTRITION,4/1/2012,3/31/2013,null,null,null
"Richter, Martin",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Matriptase Inhibitors as a Novel Class of Influenza Antivirals,143827,0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; VIROLOGY; DRUG RESEARCH,4/1/2012,3/31/2013,null,null,null
"Ghahary, Aziz",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Discovery of a Novel Anti-fibrogenic factor and its Therapeutic evaluation,150932,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; INJURY, REGENERATION",4/1/2012,3/31/2013,null,null,null
"Cynader, Max S",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Novel peptide as potential therapeutic for treatment of ischemic stroke,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction","STROKE, HEART FAILURE",4/1/2012,3/31/2013,null,null,null
"Guertin, Pierre",Universite Laval,Quebec,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,First-in-class Therapeutic Against Urinary Retention (Continence) in Patients with Chronic Spinal Cord Injury and Related Disorders,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction","SPINAL CORD DISEASE; GENITO/URINARY SYSTEM; NERVOUS SYSTEM; RENAL FUNCTION, NEPHROLOGY, UROLOGY",4/1/2012,3/31/2013,null,null,null
"Liu, Fang",Centre for Addiction and Mental Health (Toronto),Ontario,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Development of peptide therapeutics via nasal delivery for major depression disorder,150000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DEPRESSION; MENTAL AND BEHAVIOURAL DISEASES; MENTAL HEALTH; DRUG RESEARCH,4/1/2012,3/31/2013,null,null,null
"Mahuran, Don J",Hospital for Sick Children (Toronto),Ontario,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Treating Parkinson's Disease with Drugs that Increase Lysosomal B-Glucocerebrosidase Activity,157606,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",PARKINSON'S DISEASE; MENTAL AND BEHAVIOURAL DISEASES; NERVOUS SYSTEM; BIOCHEMISTRY,4/1/2012,3/31/2013,null,null,null
"Petkovich, Martin","Queen's University (Kingston, Ontario)",Ontario,Proof of Principle Program - Phase I,201109PPP,Proof of Principle,Blocking RA Metabolism: A safer approach to retinoid therapy in skin disease,135557,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",SKIN AND SUBCUTANEOUS TISSUS; METABOLISM AND NUTRITION; DRUG RESEARCH; BIOCHEMISTRY,4/1/2012,3/31/2013,null,null,null
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Cancer vaccines targeting the ganglioside tumor-marker GD2,157600,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER; IMMUNOLOGY-TRANSPLANTATION,10/1/2012,9/30/2013,null,null,null
"Agrawal, Babita",University of Alberta,Alberta,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Novel cross-protective (universal) vaccine for influenza infections,159990,0,1 yr 0 mth ,Infection and Immunity,VIRAL; IMMUNOLOGY-TRANSPLANTATION,10/1/2012,9/30/2013,null,null,null
"Husain, Mansoor",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase II,201202PP2,Proof of Principle,Development of an anti-proliferative therapeutic that disrupts CaM-cyclin E interactions in vivo.,184100,10600,1 yr 0 mth ,Circulatory and Respiratory Health,ATHEROSCLEROSIS; CANCER THERAPY GENERAL; CARDIOVASCULAR; CELL BIOLOGY,10/1/2012,9/30/2013,null,null,null
"Fernie, Geoffrey R",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase II,201202PP2,Proof of Principle,A novel point-of-care method of handling human waste in healthcare institutions: technical improvements and evaluation.,51544,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; NONE OF THE ABOVE; NOT CLASSIFIED,10/1/2012,9/30/2013,null,null,null
"Withers, Stephen G",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201202PP2,Proof of Principle,Novel Influenza Neuraminidase Inhibitors - Development of Orally Bioavailable Agents,297000,0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; VIROLOGY; POPULATION HEALTH,10/1/2012,9/30/2013,null,null,null
"Li, Shyh-Dar","Ontario Institute for Cancer Research (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,"Benchmark Cellax, a proprietary nanoparticle formulation for docetaxel, against Taxotere to treat metastatic castration resistant prostate cancer",160000,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; DRUG RESEARCH; CANCER,10/1/2012,9/30/2013,null,null,null
"Poirier, Donald",Universite Laval,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,evaluation du potentiel therapeutique in vivo d'un nouvel inhibiteur de la 17beta-HSD3 e bloquer la croissance de tumeurs xenogreffees du cancer de la prostate,157880,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; PROSTATE AND BLADDER CANCER THERAPY; DRUG RESEARCH; CANCER,10/1/2012,9/30/2013,null,null,null
"Sanche, Leon",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Developpement de composes antineoplasiques radiosensibilisants achemines par nano transporteur liposomal.,159149,0,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; BRAIN TUMORS THERAPY; CANCER; DRUG RESEARCH,10/1/2012,9/30/2013,null,null,null
"Walti, Herve",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Total liquid ventilation improves respiratory and neurological outcomes in newborn lambs with severe respiratory failure,159252,0,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; PERINATAL; NOT CLASSIFIED,10/1/2012,9/30/2013,null,null,null
"Pratt, Christine M",University of Ottawa,Ontario,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,A-CD estrogens as alternatives to Estrogen-based hormone replacement therapy,156060,0,1 yr 0 mth ,Gender and Health,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; ENDOCRINOLOGY; DRUG RESEARCH; HEALTH RESEARCH,10/1/2012,9/30/2013,null,null,null
"Legault, Pascale",Universite de Montreal,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,The ARiBo technology for isolation of ribonucleoprotein complexes,145412,13349,1 yr 0 mth ,Genetics,"CANCER THERAPY GENERAL; MULTIPLE DISEASE RELEVANCE; BIOCHEMISTRY; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",10/1/2012,9/30/2013,null,null,null
"Slim, Rima",McGill University,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,NLRP7-based diagnosis of female reproduction wastage,160000,0,1 yr 0 mth ,Genetics,PREGNANCY/BIRTH; PERINATAL; GENETICS; REPRODUCTION/PREGNANCY,10/1/2012,9/30/2013,null,null,null
"Boyd, Daniel",Dalhousie University (Nova Scotia),Nova Scotia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Commercialization of a Radiopaque Spherical Embolic Agent.,159097,0,1 yr 0 mth ,"Human Development, Child and Youth Health",NOT CLASSIFIED,10/1/2012,9/30/2013,null,null,null
"Hansen, Carl L",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Pre-commercial development of single cell antibody selection process,154120,0,1 yr 0 mth ,Infection and Immunity,MULTIPLE DISEASE RELEVANCE; MULTIDISCIPLINARY; IMMUNOLOGY-TRANSPLANTATION; HEALTH RESEARCH,10/1/2012,9/30/2013,null,null,null
"Zhou, Youwen",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,A diagnostic test for cutaneous T cell lymphomas,151660,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; BLOOD; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",10/1/2012,9/30/2013,null,null,null
"Coderre, Terence J",McGill University,Quebec,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Synergistic topical combinations for chronic pain aimed at treating microvascular dysfunction.,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; NERVOUS SYSTEM,10/1/2012,9/30/2013,null,null,null
"Kizhakkedathu, Jayachandran N",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201202PPP,Proof of Principle,Novel Polymer Based Glucose-sparing Peritoneal Dialysis Solutions for End-stage Renal Disease,160000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes","RENAL FUNCTION, NEPHROLOGY, UROLOGY",10/1/2012,9/30/2013,null,null,null
"Afilalo, Jonathan",McGill University,Quebec,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Buccal Lamin A as a Novel Biomarker for Frailty,160000,0,1 yr 0 mth ,Aging,AGING; CARDIOLOGY; CELL BIOLOGY,4/1/2013,3/31/2014,null,null,null
"Cashman, Neil R",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201209PP2,Proof of Principle,A defined cyclic peptide epitope specific to Abeta oligomers:   Active and passive vaccination in mouse models of Alzheimer's disease,300000,0,1 yr 0 mth ,Aging,ALZHEIMER'S DISEASE; AGING; NERVOUS SYSTEM,4/1/2013,3/31/2014,null,null,null
"Rosenberg, Lawrence",McGill University,Quebec,Proof of Principle Program - Phase II,201209PP2,Proof of Principle,A Novel Regenerative Drug Therapy to Restore Natural Insulin Secretion in Diabetes Mellitus,122670,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; METABOLISM/DIABETES,4/1/2013,3/31/2014,null,null,null
"Seidah, Nabil G",Institut de recherches cliniques de Montreal,Quebec,Proof of Principle Program - Phase II,201209PP2,Proof of Principle,Validation of PCSK9 single domain antibodies in cholesterol regulation in humanized mice,186128,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; METABOLISM AND NUTRITION; CARDIOVASCULAR; METABOLISM/DIABETES,4/1/2013,3/31/2014,null,null,null
"Huntsman, David G",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,PrOTYPE: An Enabling Technology to Improve Ovarian Cancer Care,154829,0,1 yr 0 mth ,Cancer Research,"NEOPLASMS; NONE OF THE ABOVE; CANCER; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",4/1/2013,3/31/2014,null,null,null
"Salcudean, Septimiu E",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Real-time Ultrasound Quantitative Elastography of the Prostate,143074,10850,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; IMAGING; CANCER,4/1/2013,3/31/2014,null,null,null
"Sherar, Michael D",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Treatment Planning and Guidance Software Platform for Minimally Invasive Ablation Therapies,145925,10000,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BIOPHYSICS; CANCER,4/1/2013,3/31/2014,null,null,null
"Stagljar, Igor",University of Toronto,Ontario,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,"Development of the Mammalian Membrane Two-Hybrid (MaMTH) technology, a novel protein interaction and drug discovery tool",160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; MULTIPLE DISEASE RELEVANCE; MOLECULAR BIOLOGY; BIOCHEMISTRY,4/1/2013,3/31/2014,null,null,null
"Bernatchez, Pascal N",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Novel compounds for treatment of pulmonary hypertension,158389,0,1 yr 0 mth ,Circulatory and Respiratory Health,HYPERTENSION; CARDIOVASCULAR; RESPIRATION,4/1/2013,3/31/2014,null,null,null
"Reynolds, Steven C","Fraser Health Authority (Surrey, BC)",British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Phase 1 Trial of a novel transvenous phrenic nerve pacer for diaphragm activation in mechanically ventilated critically ill patients.,158464,1536,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; HEALTH RESEARCH,4/1/2013,3/31/2014,null,null,null
"Tremblay, Jacques P",Universite Laval,Quebec,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Development of a treatment for Friedreich ataxia based on the administration of TALE proteins targeting the frataxin promoter.,160000,0,1 yr 0 mth ,Genetics,CONGENITAL ANOMALIES; MOLECULAR BIOLOGY,4/1/2013,3/31/2014,null,null,null
"Hancock, Robert Ernest W",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Anti-Biofilm Therapy,160000,0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INFECTIOUS AND PARASITIC; BACTERIOLOGY; DRUG RESEARCH,4/1/2013,3/31/2014,null,null,null
"Kumar, Rakesh",University of Alberta,Alberta,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Development of new class of antiviral drugs for influenza A virus infections,156590,0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INFECTIOUS AND PARASITIC; HEALTH RESEARCH; DRUG RESEARCH,4/1/2013,3/31/2014,null,null,null
"Malouin, Franeois",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Riboswitch ligand inhibitors for MRSA and staphylococci / Ligands de riboregulateurs agissant comme antibiotiques contre le SARM et les staphylocoques,157350,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC,4/1/2013,3/31/2014,null,null,null
"Nazhat, Showan N",McGill University,Quebec,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Injectable dense collagen-silk fibroin derived polypeptide hydrogels for bone regenerative therapy,156393,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; DENTAL DISEASE (INCL. ORAL BIOLOGY); MUSCLE, BONE, OR JOINT; AGING",4/1/2013,3/31/2014,null,null,null
"Tamimi, Faleh",McGill University,Quebec,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Biocompatible inorganic nanogel system for medical applications,150160,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INJURY, REGENERATION; DENTAL SCIENCE - Oral Biology; DRUG RESEARCH",4/1/2013,3/31/2014,null,null,null
"Ross, Ruth A",University of Toronto,Ontario,Proof of Principle Program - Phase I,201209PPP,Proof of Principle,Development and Testing of Small Molecule Allosteric Modulators for the Treatment of Pain.,157999,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE DISEASE RELEVANCE; ARTHRITIS/OSTEOARTHRITIS; DRUG RESEARCH; AGING,4/1/2013,3/31/2014,null,null,null
"Agrawal, Babita",University of Alberta,Alberta,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,New dual-mode antiviral agents for the treatment of hepatitis C virus infection,159984,0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUG RESEARCH; VIROLOGY,10/1/2013,9/30/2014,null,null,null
"Burt, Helen M",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201302PP2,Proof of Principle,Intravesical Docetaxel Formulation for the Treatment of Ta/T1 Stage Bladder Cancer,294600,0,1 yr 0 mth ,Cancer Research,"PROSTATE AND BLADDER CANCER THERAPY; CANCER; RENAL FUNCTION, NEPHROLOGY, UROLOGY",10/1/2013,9/30/2014,null,null,null
"Meek, Robert N",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201302PP2,Proof of Principle,Minimally Invasive Curved Intramedullary Fixation (MICIF) for pelvic bone fractures,300000,0,1 yr 0 mth ,Health Services and Policy Research,"NONE OF THE ABOVE; MUSCLE, BONE, OR JOINT; HEALTH RESEARCH",10/1/2013,9/30/2014,null,null,null
"Bosse, Yohan",Universite Laval,Quebec,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Prognostic gene signature for stage I lung adenocarcinoma,148348,0,1 yr 0 mth ,Cancer Research,LUNG CANCER; SUPPLEMENTARY CLASSIFICATIONS; CANCER; GENETICS,10/1/2013,9/30/2014,null,null,null
"Li, Shyh-Dar","Ontario Institute for Cancer Research (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Heat-triggered Chemotherapy to Treat Refractory Breast Cancer at the Chest Wall,160000,0,1 yr 0 mth ,Cancer Research,DRUG RESEARCH; CANCER,10/1/2013,9/30/2014,null,null,null
"Stojdl, David F",Children's Hospital of Eastern Ontario Research Institute Inc,Ontario,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Chimeric Oncolytic Virus for Brain Cancer Treatment,160000,0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; CANCER THERAPY GENERAL,10/1/2013,9/30/2014,null,null,null
"Brouillette, Martin",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Device for recanalization of peripheral and coronary arteries,155180,0,1 yr 0 mth ,Circulatory and Respiratory Health,CORONARY CIRCULATION (INCL. INSUFFICIENCY); CARDIOLOGY; CARDIOVASCULAR,10/1/2013,9/30/2014,null,null,null
"Jarvi, Keith A",Sinai Health System (Toronto),Ontario,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Prediction of successful sperm retrieval in patients with non-obstructive azoospermia using a panel of protein biomarkers measured in seminal plasma,154660,0,1 yr 0 mth ,"Human Development, Child and Youth Health","INFERTILITY MALE; PREGNANCY/BIRTH; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; REPRODUCTION/PREGNANCY",10/1/2013,9/30/2014,null,null,null
"Yang, Victor X",Toronto Metropolitan University,Ontario,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Integrated Surgical Lighting and Navigation System,156230,2200,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; MULTIDISCIPLINARY; IMAGING; MUSCLE, BONE, OR JOINT",10/1/2013,9/30/2014,null,null,null
"Beaulieu, Martin",Universite Laval,Quebec,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,Cells lines for screening GPCR/Nav signaling compound,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; CELL BIOLOGY,10/1/2013,9/30/2014,null,null,null
"Guertin, Pierre",Universite Laval,Quebec,Proof of Principle Program - Phase I,201302PPP,Proof of Principle,A Novel Class of Drug Treatment Against Chronic Constipation in Spinal Cord-Injured People,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",SPINAL CORD DISEASE; GASTRO-INTESTINAL DISEASE; NERVOUS SYSTEM; GASTROINTESTINAL (LIVER),10/1/2013,9/30/2014,null,null,null
"Yanow, Stephanie K",University of Alberta,Alberta,Proof of Principle Program - Phase II,201309PP2,Proof of Principle,A field-deployable malaria and fever diagnostic system,143250,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; POPULATION HEALTH; INTERNATIONAL HEALTH,4/1/2014,3/31/2015,null,null,null
"Williams, Jason",Nova Scotia Health Authority (Halifax),Nova Scotia,Proof of Principle Program - Phase II,201309PP2,Proof of Principle,The Production of Decellularized Human Skin to Treat Chronic Diabetic Ulcers,145760,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DIABETES MELLITUS; SKIN AND SUBCUTANEOUS TISSUS; HEALTH RESEARCH; METABOLISM/DIABETES,4/1/2014,3/31/2015,null,null,null
"Beaulieu, Jean-Franeois",Universite de Sherbrooke,Quebec,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Improving the diagnosis of colorectal cancer using fecal mRNA and protein markers: The integrin alpha 6A subunit,160000,0,1 yr 0 mth ,Cancer Research,GASTRO-INTESTINAL CANCER; GASTRO-INTESTINAL CANCER THERAPY; GASTROINTESTINAL (LIVER); CANCER,4/1/2014,3/31/2015,null,null,null
"Bell, John C",Ottawa Hospital Research Institute,Ontario,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Biological Viral Sensitizers for GMP Manufacturing,123000,37000,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; VIRAL; CANCER; VIROLOGY,4/1/2014,3/31/2015,null,null,null
"Poirier, Donald",Universite Laval,Quebec,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,evaluation du potentiel therapeutique in vivo d'un nouvel inhibiteur de la steroede sulfatase combinant des proprietes osteogenique et antiestrogenique pour le traitement des cancers du sein et de la prostate,159756,0,1 yr 0 mth ,Cancer Research,BREAST CANCER THERAPY; OSTEOPOROSIS; CANCER; DRUG RESEARCH,4/1/2014,3/31/2015,null,null,null
"Tsantrizos, Youla S",McGill University,Quebec,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Benchmark proprietary pyridine- and thienopyrimidine-based bisphosphonates against the standard of care drug Zometae in the treatment of multiple myeloma,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; BONE CANCER THERAPY; DRUG RESEARCH; CANCER,4/1/2014,3/31/2015,null,null,null
"Wu, Xiao Yu S",University of Toronto,Ontario,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Preclinical evaluation of multifunctional polymer nanoparticles for targeted brain cancer therapy,160000,0,1 yr 0 mth ,Cancer Research,BRAIN TUMORS THERAPY; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; CANCER,4/1/2014,3/31/2015,null,null,null
"Charron, Thierry",CIUSSS du Nord-de-l'Ile-de Montreal - Hepital Sacre Coeur,Quebec,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Innovative device to reduce myocardial infarct size and no-reflow : Proof of concepts in humans,159300,0,1 yr 0 mth ,Circulatory and Respiratory Health,MYOCARDIAL INFARCTION; CARDIOLOGY; CARDIOVASCULAR,4/1/2014,3/31/2015,null,null,null
"Nanthakumar, Kumaraswamy",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Novel Mapping Methodology for Identifying Arrhythmia Circuit.,158375,0,1 yr 0 mth ,Circulatory and Respiratory Health,CARDIOLOGY; ARRHYTHMIAS; CARDIOVASCULAR,4/1/2014,3/31/2015,null,null,null
"Fenster, Aaron",Western University (Ontario),Ontario,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,3D Ultrasound Scanner System For Management Of Intraventricular Hemorrhage In Preterm Neonates,148062,0,1 yr 0 mth ,"Human Development, Child and Youth Health",MULTIDISCIPLINARY; NONE OF THE ABOVE; IMAGING; BIOPHYSICS,4/1/2014,3/31/2015,null,null,null
"Gatignol, Anne",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Development of antisense-based small RNA agents targeting the GAG open reading frame of HIV-1 RNA for use in gene and drug therapy against HIV-1 infection.,159550,0,1 yr 0 mth ,Infection and Immunity,AIDS; VIRAL; VIROLOGY; MOLECULAR BIOLOGY,4/1/2014,3/31/2015,null,null,null
"Kumar, Rakesh",University of Alberta,Alberta,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Development of novel chemotherapeutics for tuberculosis,159850,0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; INFECTIOUS AND PARASITIC; DRUG RESEARCH; BACTERIOLOGY,4/1/2014,3/31/2015,null,null,null
"Roberge, Michel",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Preclinical Development of a novel M2 Channel Inhibitor for the Treatment and Prevention of Influenza,160000,0,1 yr 0 mth ,Infection and Immunity,VIRAL; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; VIROLOGY,4/1/2014,3/31/2015,null,null,null
"Ghahary, Aziz",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Re -constitutable skin substitute powder kit,147089,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; INJURY, REGENERATION",4/1/2014,3/31/2015,null,null,null
"Hebert, Marc",Universite Laval,Quebec,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,"Diagnostic differentiel de la schizophrenie, la depression bipolaire et la depression majeure e l'aide de l'electroretinographie",159700,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DEPRESSION; MENTAL HEALTH,4/1/2014,3/31/2015,null,null,null
"Cummins, Carolyn L",University of Toronto,Ontario,Proof of Principle Program - Phase I,201309PPP,Proof of Principle,Developing a Novel Therapeutic for Cushing's Syndrome,160000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",ENDOCRINOLOGY; MUSCULO SKELETAL; DRUG RESEARCH,4/1/2014,3/31/2015,null,null,null
"Diallo, Jean-Simon",Ottawa Hospital Research Institute,Ontario,Proof of Principle Program - Phase II,201402PP2,Proof of Principle,Evaluation of viral sensitizer technology in improving egg-based influenza vaccine manufacturing processes,222143,77857,1 yr 0 mth ,Infection and Immunity,VIRAL; NONE OF THE ABOVE; VIROLOGY; BIOCHEMISTRY,10/1/2014,9/30/2015,null,null,null
"Kizhakkedathu, Jayachandran N",University of British Columbia,British Columbia,Proof of Principle Program - Phase II,201402PP2,Proof of Principle,Preclinical Development of a Glucose-Free Peritoneal Dialysis Solution,289799,5000,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes","RENAL FUNCTION, NEPHROLOGY, UROLOGY",10/1/2014,9/30/2015,null,null,null
"Bohbot, Veronique",CIUSSS de l'Ouest-de-l'Ile-de-Montreal-Douglas Hospital,Quebec,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Validation of a fully automated virtual reality based spatial memory improvement program that promotes healthy aging,160000,0,1 yr 0 mth ,Aging,ALZHEIMER'S DISEASE; HEALTH PROMOTION,10/1/2014,9/30/2015,null,null,null
"Conway, Edward M",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Novel therapeutic approach for 'wet' and 'dry' age-related macular degeneration,160000,0,1 yr 0 mth ,Aging,DISEASES AFFECTING SPEECH/VISION/HEARING; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; AGING,10/1/2014,9/30/2015,null,null,null
"Cherkasov, Artem",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,First-in-Class Small-molecule Inhibitors Selectively Targeting the DNA-binding Domain of Human Androgen Receptor and Its Splice Variants for the Treatment of Resistant Prostate Cancer,150030,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; CANCER THERAPY GENERAL; CANCER; DRUG RESEARCH,10/1/2014,9/30/2015,null,null,null
"Jaffray, David A",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Advanced Handheld SPECT System for Intraoperative Guidance,159845,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,10/1/2014,9/30/2015,null,null,null
"Hanrahan, John W",McGill University,Quebec,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,CFTR modulators as a potential new therapeutic paradigm to treat individuals with COPD,159665,0,1 yr 0 mth ,Circulatory and Respiratory Health,CHRONIC OBSTRUCTIVE LUNG DISEASE; RESPIRATION; HEALTH RESEARCH,10/1/2014,9/30/2015,null,null,null
"Kastrup, Christian J",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Self-Propelling Hemostatic Particles that Treat Severe Bleeding,159788,0,1 yr 0 mth ,Circulatory and Respiratory Health,CLOTTING DEFECTS/THROMBOSIS; PREGNANCY/BIRTH; CARDIOVASCULAR; BLOOD,10/1/2014,9/30/2015,null,null,null
"Kelley, Shana O",University of Toronto,Ontario,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,The xViva CTC capture chip: a device for tumor cell sorting and classification,160000,0,1 yr 0 mth ,Genetics,PROSTATE AND BLADDER CANCER; CANCER THERAPY GENERAL; GENETICS; CANCER,10/1/2014,9/30/2015,null,null,null
"Alfieri, Carolina","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Development of a peptide mimetic vaccine for prevention of Epstein-Barr virus infectious mononucleosis and related cancers.,159612,0,1 yr 0 mth ,Infection and Immunity,VIRAL; INFECTIOUS AND PARASITIC; VIROLOGY; IMMUNOLOGY-TRANSPLANTATION,10/1/2014,9/30/2015,null,null,null
"Mahony, James B",McMaster University,Ontario,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Evaluation of a Novel Chlamydia Vaccine Based on Type III Secretion Proteins,159000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; INFERTILITY FEMALE; HEALTH RESEARCH; BACTERIOLOGY,10/1/2014,9/30/2015,null,null,null
"Putnins, Edward E",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Development of Novel Polar MAO B Inhibitors for the Treatment of Epithelial Barrier Diseases,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DENTAL DISEASE (INCL. ORAL BIOLOGY); DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DENTAL SCIENCE - Oral Biology; DRUG RESEARCH,10/1/2014,9/30/2015,null,null,null
"Tabrizian, Maryam",McGill University,Quebec,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,A Novel Injectable Chitosan Sponge Containing BMP-7 as a Therapeutic Intervention for Accelerated Bone Formation in a Critical Size Defect Rat Model,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"BONE CANCER; INJURY, REGENERATION; MUSCLE, BONE, OR JOINT; DRUG RESEARCH",10/1/2014,9/30/2015,null,null,null
"Fon, Edward A",McGill University,Quebec,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Targeting Alpha-Synuclein Propagation in the Treatment of Parkinson's Disease and Other Synucleinopathies,159946,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",PARKINSON'S DISEASE; AGING; NERVOUS SYSTEM; DRUG RESEARCH,10/1/2014,9/30/2015,null,null,null
"Kotra, Lakshmi P",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,In vivo efficacy studies on KP-218 as a potential MS therapeutic agent,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE SCLEROSIS; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS,10/1/2014,9/30/2015,null,null,null
"Steinberg, Gregory R",McMaster University,Ontario,Proof of Principle Program - Phase I,201402PPP,Proof of Principle,Development of a new therapy targeting adipose tissue metabolism for the treatment of obesity,160000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",OBESITY; ENDOCRINOLOGY; METABOLISM/DIABETES,10/1/2014,9/30/2015,null,null,null
"Reynolds, Steven C","Fraser Health Authority (Surrey, BC)",British Columbia,Proof of Principle Program - Phase II,201409PP2,Proof of Principle,"Development of a novel, temporary, transcutaneously placed, transvenous phrenic nerve pacer for diaphragm activation in critically ill patients",268499,2000,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; HEALTH RESEARCH,4/1/2015,3/31/2016,null,null,null
"Ross, Ruth A",University of Toronto,Ontario,Proof of Principle Program - Phase II,201409PP2,Proof of Principle,Development and Commercialisation of Allosteric Modulators for the Treatment of Pain,189920,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,MULTIPLE DISEASE RELEVANCE; MUSCULO SKELETAL,4/1/2015,3/31/2016,null,null,null
"Trifiro, Mark A",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Targeting novel BioNanofluids for prostate cancer therapy,148240,11000,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; PROSTATE AND BLADDER CANCER THERAPY,4/1/2015,3/31/2016,null,null,null
"Tsao, Ming-Sound",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of a monoclonal antibody for integrin alpha-11 to treat lung cancer,160000,0,1 yr 0 mth ,Cancer Research,LUNG CANCER; LUNG CANCER THERAPY; CANCER; DRUG RESEARCH,4/1/2015,3/31/2016,null,null,null
"Chauhan, Vijay S",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Rotor Mapping in Human Atrial Fibrillation,149015,10634,1 yr 0 mth ,Circulatory and Respiratory Health,ARRHYTHMIAS; CARDIOLOGY; CARDIOVASCULAR; HEALTH RESEARCH,4/1/2015,3/31/2016,null,null,null
"Dyck, Jason R",University of Alberta,Alberta,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Preclinical Development and Optimization of Small Molecules for the Treatment of Atrial Fibrillation,160000,0,1 yr 0 mth ,Circulatory and Respiratory Health,ARRHYTHMIAS; CARDIOLOGY; CARDIOVASCULAR; DRUG RESEARCH,4/1/2015,3/31/2016,null,null,null
"Withers, Stephen G",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Extending circulation time of protein therapeutics by capping glycan structures with 7F-Sialic acids,159981,0,1 yr 0 mth ,Genetics,MULTIDISCIPLINARY; BIOCHEMISTRY,4/1/2015,3/31/2016,null,null,null
"Sinton, David A",University of Toronto,Ontario,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,High Quality Sperm Selection for Assisted Reproductive Technology,159904,0,1 yr 0 mth ,"Human Development, Child and Youth Health",INFERTILITY MALE; INFERTILITY FEMALE; REPRODUCTION/PREGNANCY,4/1/2015,3/31/2016,null,null,null
"Bergeron, Michel G",Universite Laval,Quebec,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,"Developpement, optimisation et multiplexage d'un oligonucleotide synthetique permettant l'amplification d'ADN et l'hybridation sur support solide en une seule etape. PDP PhaseI",160000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; MOLECULAR BIOLOGY; BACTERIOLOGY,4/1/2015,3/31/2016,null,null,null
"Grierson, David S",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of Specific Inhibitors of HIV pre-mRNA Alternative Splicing: A New Anti-HIV/AIDS Strategy,160000,0,1 yr 0 mth ,Infection and Immunity,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; AIDS; DRUG RESEARCH; VIROLOGY,4/1/2015,3/31/2016,null,null,null
"Yanow, Stephanie K",University of Alberta,Alberta,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Long-term preservation of a whole parasite malaria vaccine for storage and delivery in the tropics,160000,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; BLOOD; INTERNATIONAL HEALTH; HEALTH RESEARCH,4/1/2015,3/31/2016,null,null,null
"Flynn, Lauren E",Western University (Ontario),Ontario,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of novel porous extracellular matrix-derived bioscaffolds for cutaneous wound healing,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"SKIN AND SUBCUTANEOUS TISSUS; INJURY, REGENERATION; HEALTH RESEARCH; CELL BIOLOGY",4/1/2015,3/31/2016,null,null,null
"Logsetty, Sarvesh",University of Manitoba,Manitoba,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,The effects of a novel hydrogel coating on commercial antimicrobial dressings.,157633,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,SKIN AND SUBCUTANEOUS TISSUS; INFECTIOUS AND PARASITIC; BIOCHEMISTRY; DRUG RESEARCH,4/1/2015,3/31/2016,null,null,null
"Moreau, Alain","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Preclinical Validation of a Disease-Modifying Osteoarthritis Drug,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"ARTHRITIS/OSTEOARTHRITIS; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MUSCLE, BONE, OR JOINT; DRUG RESEARCH",4/1/2015,3/31/2016,null,null,null
"Young, Robert N","Simon Fraser University (Burnaby, B.C.)",British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Development of a novel conjugate drug for local delivery in bone grafts: Efficacy study on vascularization and osteogenesis after local delivery in a dental implant jaw model,157500,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,DENTAL DISEASE (INCL. ORAL BIOLOGY); DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; DRUG RESEARCH; DENTAL SCIENCE - Oral Biology,4/1/2015,3/31/2016,null,null,null
"Koeberle, Paulo D",University of Toronto,Ontario,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Peptide therapeutics for preventing retinal ganglion cell apoptosis,149949,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",GLAUCOMA; DISEASES AFFECTING SPEECH/VISION/HEARING,4/1/2015,3/31/2016,null,null,null
"Du, Caigan",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201409PPP,Proof of Principle,Preclinical Development of a Novel Organ Transplant Solution,160000,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes","GENITO/URINARY SYSTEM; MULTIPLE DISEASE RELEVANCE; RENAL FUNCTION, NEPHROLOGY, UROLOGY; DRUG RESEARCH",4/1/2015,3/31/2016,null,null,null
"Brodt, Pnina",Research Institute of the McGill University Health Centre,Quebec,Proof of Principle Program - Phase II,201502PP2,Proof of Principle,An IGF-Trap for the treatment of breast cancer: consolidation of the pre-clinical profile and commercialization.,299934,0,1 yr 0 mth ,Cancer Research,BREAST CANCER; BREAST CANCER THERAPY; CANCER; DRUG RESEARCH,10/1/2015,9/30/2016,null,null,null
"Zhang, Li",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase II,201502PP2,Proof of Principle,A new cellular immunotherapy to treat acute myeloid leukemia,183670,35500,1 yr 0 mth ,Cancer Research,MULTIDISCIPLINARY; IMMUNOLOGY-TRANSPLANTATION; CANCER,10/1/2015,9/30/2016,null,null,null
"Greer, John J",University of Alberta,Alberta,Proof of Principle Program - Phase II,201502PP2,Proof of Principle,Ampakine Therapy for Alleviating Respiratory Depression,145440,0,1 yr 0 mth ,Circulatory and Respiratory Health,RESPIRATION; NONE OF THE ABOVE; NERVOUS SYSTEM,10/1/2015,9/30/2016,null,null,null
"Gibbings, Derrick J",University of Ottawa,Ontario,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Technology to build a drug delivery platform for silencing RNAs using exosomes,159941,0,1 yr 0 mth ,Aging,MULTIPLE DISEASE RELEVANCE; MULTIDISCIPLINARY; HEALTH RESEARCH; DRUG RESEARCH,10/1/2015,9/30/2016,null,null,null
"Tremblay, Jacques P",Universite Laval,Quebec,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Alzheimer treatment based on the editing of the Amyloid Precursor Protein gene,159931,0,1 yr 0 mth ,Aging,ALZHEIMER'S DISEASE; AGING; MOLECULAR BIOLOGY; GENETICS,10/1/2015,9/30/2016,null,null,null
"Yoo, Paul",University of Toronto,Ontario,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Minimally-Invasive Method of Selectively Activating Posterior Tibial Nerve Afferents for Treating Overactive Bladder,155800,4000,1 yr 0 mth ,Aging,"GENITO/URINARY SYSTEM; RENAL FUNCTION, NEPHROLOGY, UROLOGY",10/1/2015,9/30/2016,null,null,null
"Benard, Francois",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,"Advancing the clinical development of [18F]AMBF3-TATE, a novel imaging probe for neuroendocrine tumours",160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER; IMAGING,10/1/2015,9/30/2016,null,null,null
"Ma, Hongshen",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Pre-commercial Development of Microfluidic Technology for Deformability based Separation of Circulating Tumor Cells,160000,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; BLOOD; CANCER,10/1/2015,9/30/2016,null,null,null
"Macaulay, Calum E",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Optically-Guided Biopsy for Improved Diagnosis of Peripheral Pulmonary Nodules,146470,0,1 yr 0 mth ,Cancer Research,LUNG CANCER; NEOPLASMS; CANCER; HEALTH RESEARCH,10/1/2015,9/30/2016,null,null,null
"Sidhu, Sachdev S",University of Toronto,Ontario,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Highly specific therapeutic-grade anti-FGFR1 antibodies with anti-proliferative effects,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; MOLECULAR BIOLOGY; CANCER,10/1/2015,9/30/2016,null,null,null
"Wu, Jian Hui",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Development of novel pan-inhibitors of the androgen receptor variants as effective therapeutics for castration-resistant prostate cancer,160000,0,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER; DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS,10/1/2015,9/30/2016,null,null,null
"Dumont, Guy A",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Certifiably safe closed-loop control of anesthesia,158740,0,1 yr 0 mth ,Circulatory and Respiratory Health,HEALTH RESEARCH,10/1/2015,9/30/2016,null,null,null
"Kim, Peter K",Hospital for Sick Children (Toronto),Ontario,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,A novel therapeutic treatment for Zellweger Spectrum Disorder,160000,0,1 yr 0 mth ,"Human Development, Child and Youth Health",METABOLISM AND NUTRITION; CONGENITAL ANOMALIES; CELL BIOLOGY; GENETICS,10/1/2015,9/30/2016,null,null,null
"Weksberg, Rosanna",Hospital for Sick Children (Toronto),Ontario,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Implementation and Commercialization of a Novel DNA Methylation-Based Diagnostic Tool,160000,0,1 yr 0 mth ,"Human Development, Child and Youth Health","DETERMINANTS OF HEALTH; MENTAL AND BEHAVIOURAL DISEASES; GENETICS; GENOMICS, PROTEOMICS, AND BIOINFORMATICS",10/1/2015,9/30/2016,null,null,null
"Brukner, Ivan",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,A new qPCR method for the assessment of total/relative bacterial load from stool samples: C difficile show case,131513,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; MULTIDISCIPLINARY; BACTERIOLOGY; MOLECULAR BIOLOGY,10/1/2015,9/30/2016,null,null,null
"de Rezende, Joao B",Unity Health Toronto,Ontario,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,A Non-Traumatic Binder for Temporary Abdominal Wall Closure,115768,0,1 yr 0 mth ,Infection and Immunity,NONE OF THE ABOVE; NOT CLASSIFIED,10/1/2015,9/30/2016,null,null,null
"Sheppard, Donald C",Research Institute of the McGill University Health Centre,Quebec,Proof of Principle Program - Phase I,201502PPP,Proof of Principle,Recombinant hydrolases as anti-biofilm therapies for Aspergillus infections,151459,0,1 yr 0 mth ,Infection and Immunity,INFECTIOUS AND PARASITIC; PNEUMONIA; BACTERIOLOGY; IMMUNOLOGY-TRANSPLANTATION,10/1/2015,9/30/2016,null,null,null
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Proof of Principle Program - Phase II,201509PP2,Proof of Principle,Therapy for motor neuron degeneration diseases targeting the opposing ligand-dependent signals of two TrkC receptor isoforms,300000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",AMYOTROPHIC LATERAL SCLEROSIS (ALS); DISEASES AFFECTING SPEECH/VISION/HEARING; NERVOUS SYSTEM; DRUG RESEARCH,4/1/2016,3/31/2017,,,
"Liu, Fang",Centre for Addiction and Mental Health (Toronto),Ontario,Proof of Principle Program - Phase II,201509PP2,Proof of Principle,Development and commercialisation of a novel treatment for multiple sclerosis,299101,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",MULTIPLE SCLEROSIS; MENTAL AND BEHAVIOURAL DISEASES; DRUG RESEARCH; NERVOUS SYSTEM,4/1/2016,3/31/2017,null,null,null
"Dutta, Tilak",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Pressure ulcer prevention: a novel prompting system for patient repositioning,137401,0,1 yr 0 mth ,Aging,SKIN AND SUBCUTANEOUS TISSUS; MULTIPLE DISEASE RELEVANCE; AGING; GERIATRICS,4/1/2016,3/31/2017,null,null,null
"Fenster, Aaron",Western University (Ontario),Ontario,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,MR-Guided Focal Ablation of Prostate Cancer,143110,10313,1 yr 0 mth ,Cancer Research,PROSTATE AND BLADDER CANCER THERAPY; IMAGING; CANCER,4/1/2016,3/31/2017,null,null,null
"Lerouge, Sophie",ecole de technologie superieure (Montreal),Quebec,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Injectable thermosensitive hydrogel as delivery vehicle of lymphocytes for cancer immunotherapy,141000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,4/1/2016,3/31/2017,null,null,null
"Mcalpine, Jessica N",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,PROMISE: A Proactive Molecular-Based Classification Tool to Improve Endometrial Cancer Management,160000,0,1 yr 0 mth ,Cancer Research,CANCER THERAPY GENERAL; CANCER,4/1/2016,3/31/2017,null,null,null
"Poirier, Donald",Universite Laval,Quebec,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Optimisation du potentiel therapeutique de derives aminosteroedes contre le cancer de l'ovaire,157700,2300,1 yr 0 mth ,Cancer Research,DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; CANCER THERAPY GENERAL; DRUG RESEARCH; CANCER,4/1/2016,3/31/2017,null,null,null
"Roberge, Michel",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Preclinical evaluation of a gentamicin analog as a treatment for genetic diseases and cancer due to a premature termination codon.,150059,0,1 yr 0 mth ,Genetics,MULTIPLE DISEASE RELEVANCE; CANCER THERAPY GENERAL; CANCER; GENETICS,4/1/2016,3/31/2017,null,null,null
"Jarvi, Keith A",Sinai Health System (Toronto),Ontario,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Prediction of successful sperm retrieval in patients with non-obstructive azoospermia using TEX101 protein measured in seminal plasma by ELISA,160000,0,1 yr 0 mth ,"Human Development, Child and Youth Health","INFERTILITY MALE; PREGNANCY/BIRTH; GENOMICS, PROTEOMICS, AND BIOINFORMATICS; REPRODUCTION/PREGNANCY",4/1/2016,3/31/2017,null,null,null
"Doschak, Michael R",University of Alberta,Alberta,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Bone-Seeking Iron Oxide Nanoparticles for Imaging Bone Metabolism,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MUSCULO SKELETAL; DRUG RESEARCH; MUSCLE, BONE, OR JOINT",4/1/2016,3/31/2017,null,null,null
"Ross, Ruth A",University of Toronto,Ontario,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Development and therapeutic validation of GPR55 modulators for the treatment of osteoclast-mediated disorders,155600,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"OSTEOPOROSIS; BONE CANCER; MUSCLE, BONE, OR JOINT; CANCER",4/1/2016,3/31/2017,null,null,null
"Whyne, Cari M","Sunnybrook Health Sciences Centre (Toronto, Ontario)",Ontario,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,"""Bone Tape"": Optimization of a novel method for reconstructing the craniomaxillofacial skeleton",160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"MUSCULO SKELETAL; MUSCLE, BONE, OR JOINT",4/1/2016,3/31/2017,null,null,null
"Wither, Joan E",University Health Network (Toronto),Ontario,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Development of a test for the early diagnosis and monitoring of lupus nephritis,160000,0,1 yr 0 mth ,Musculoskeletal Health and Arthritis,"LUPUS; GENITO/URINARY SYSTEM; MUSCLE, BONE, OR JOINT; RENAL FUNCTION, NEPHROLOGY, UROLOGY",4/1/2016,3/31/2017,null,null,null
"Gobbi, Gabriella",McGill University,Quebec,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Novel first-in-class MT2 melatonin receptor partial agonists for neuropathic pain,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",DRUGS- PHARMACEUTICAL SCIENCE/CHEMISTRY & NON MEDICAL USE OF DRUGS; MENTAL AND BEHAVIOURAL DISEASES; DRUG RESEARCH; NERVOUS SYSTEM,4/1/2016,3/31/2017,null,null,null
"Snutch, Terrance P",University of British Columbia,British Columbia,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Identification of SLC26A11 blockers to prevent neuronal swelling and cell death,160000,0,1 yr 0 mth ,"Neurosciences, Mental Health and Addiction",CNS ORGANIC; MULTIPLE DISEASE RELEVANCE; DRUG RESEARCH; NERVOUS SYSTEM,4/1/2016,3/31/2017,null,null,null
"Shapiro, James",University of Alberta,Alberta,Proof of Principle Program - Phase I,201509PPP,Proof of Principle,Preclinical Development of Novel Biomaterials for the Creation of a Deviceless Pre-Vascularized Site for Islet and Cellular Transplantation,157126,0,1 yr 0 mth ,"Nutrition, Metabolism and Diabetes",DIABETES MELLITUS; ENDOCRINOLOGY; IMMUNOLOGY-TRANSPLANTATION; METABOLISM/DIABETES,4/1/2016,3/31/2017,null,null,null
"Sarunic, Marinko V","Simon Fraser University (Burnaby, B.C.)",British Columbia,Project Grant,201809PJT,Commercialization,Sensorless Adaptive Optics Optical Coherence Tomography for Clinical Ophthalmology,493425,0,3 yrs 0 mth ,Aging,Biomedical Engineering-Biomedical Imaging,4/1/2017,3/31/2018,null,null,null
"C.-Gaudreault, Rene",Universite Laval,Quebec,Project Grant,201709PJT,Commercialization,Validation of Highly Potent Substituted Phenyl Alkylureas as Antipsoriatic Agents,497250,0,3 yrs 0 mth ,Cancer Research,"Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Action, Toxicology and Metabolism; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",4/1/2018,3/31/2021,null,null,null
"Gleave, Martin E",University of British Columbia,British Columbia,Project Grant,201709PJT,Commercialization,Preclinical development of a novel androgen receptor antagonist to treat castration-resistant prostate cancer,351900,0,2 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,4/1/2018,3/31/2020,null,null,null
"Poirier, Donald",Universite Laval,Quebec,Project Grant,201709PJT,Commercialization,Demonstration de l'efficacite du premier inhibiteur irreversible et selectif de la  17beta-HSD1 pour le traitement des cancers du sein sensibles aux estrogenes,279226,0,2 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,4/1/2018,3/31/2020,null,null,null
"Zeng, Haishan",University of British Columbia,British Columbia,Project Grant,201709PJT,Commercialization,Real-time Endoscopic Raman Spectroscopy for Improving Dysplasia/Colorectal Cancer Detection in Patients with Inflammatory Bowel Diseases,508724,0,4 yrs 0 mth ,Cancer Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Cancer-Clinical Oncology; Digestive, Endocrine and Excretory Systems-Gastroenterology and Hepatology",4/1/2018,3/31/2022,null,null,null
"Coles, John G",Hospital for Sick Children (Toronto),Ontario,Project Grant,201709PJT,Commercialization,Integrin Linked Kinase as a Novel Therapeutic Target for Heart Failure,512550,0,3 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Cardiovascular and Circulatory Sciences",4/1/2018,3/31/2021,null,null,null
"Sutherland, Garnette R",University of Calgary,Alberta,Project Grant,201709PJT,Commercialization,The SmartForceps System: An intelligent and innovative tool technology for recording surgical performance and skill,520200,0,3 yrs 0 mth ,Health Services and Policy Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Health Services and Systems-Healthcare Safety & Quality Improvement",4/1/2018,3/31/2021,null,null,null
"Weaver, Donald F",University Health Network (Toronto),Ontario,Project Grant,201709PJT,Commercialization,"Design and Development of Brain Permeant Indoleamine-2,3-Dioxygenase Inhibitors",765000,0,4 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Neurosciences-Neurological disorders",4/1/2018,3/31/2022,null,null,null
"Kazem-Moussavi, Zahra M",University of Manitoba,Manitoba,Project Grant,201803PJT,Commercialization,Acoustical Device for Obstructive Sleep Apnea Severity Prediction during Wakefulness,367200,0,3 yrs 0 mth ,Circulatory and Respiratory Health,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Health Determinants-Etiology of Disease and Conditions",10/1/2018,9/30/2021,null,null,null
"Towler, Mark R",Toronto Metropolitan University,Ontario,Project Grant,201803PJT,Commercialization,"Development of a Proprietary, Glass-Based Adhesive for Sternal Fixation and Stabilisation.",602438,0,3 yrs 0 mth ,Musculoskeletal Health and Arthritis,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Musculoskeletal Health-Bone, Skin and Cartilage Sciences",10/1/2018,9/30/2021,null,null,null
"Sibille, Etienne",Centre for Addiction and Mental Health (Toronto),Ontario,Project Grant,201803PJT,Commercialization,Novel therapeutic targeting for cognitive deficits in depression and aging,550800,0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction",Mental Health and Behavioural Conditions-Mental Health and Addiction; Aging-Aging Process and Biological Determinants of Aging,10/1/2018,9/30/2021,null,null,null
"Garnis, Cathie",University of British Columbia,British Columbia,Project Grant,201809PJT,Commercialization,Blood based biomarker for the early detection of recurrent head and neck cancer,539324,0,4 yrs 0 mth ,Cancer Research,Cancer-Clinical Oncology,4/1/2019,3/31/2023,null,null,null
"St-Pierre, Yves","INRS - (Quebec, QC)",Quebec,Project Grant,201809PJT,Commercialization,GAL-7-specific nanobodies for treatment of triple-negative breast cancer,371024,0,3 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property,4/1/2019,3/31/2022,null,null,null
"Wu, Xiao Yu S",University of Toronto,Ontario,Project Grant,201809PJT,Commercialization,Development of a Smart Tumor-Activated Nanodiagnostic System for Sensitive Detection of Solid Tumors and Metastases,470475,0,3 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Biomedical Engineering-Biomedical Imaging,4/1/2019,3/31/2022,null,null,null
"Yousef, George M",Unity Health Toronto,Ontario,Project Grant,201809PJT,Commercialization,Development of the first pre-operative serum exosomal miRNA test to guide treatment decision in prostate cancer,573752,0,4 yrs 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis,4/1/2019,3/31/2023,null,null,null
"Paganelli, Massimiliano","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Project Grant,201809PJT,Commercialization,Stem cell-derived Encapsulated Liver Tissue to treat liver failure without immunosuppression: technology maturation towards clinical translation,497249,0,3 yrs 0 mth ,"Nutrition, Metabolism and Diabetes","Biomedical Engineering-Regenerative Medicine and Tissue Engineering; Digestive, Endocrine and Excretory Systems-Gastroenterology and Hepatology; Commercialization-Technology Transfer",4/1/2019,3/31/2022,null,null,null
"Agrawal, Babita",University of Alberta,Alberta,Project Grant,201903PJT,Commercialization,Development of a novel universal (cross-protective) vaccine technology for influenza viruses,367200,0,3 yrs 0 mth ,Infection and Immunity,"Commercialization-Intellectual Property; Immunology and Infection-Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics (including vaccines)",10/1/2019,9/30/2022,null,null,null
"Minchinton, Andrew I",University of British Columbia,British Columbia,Project Grant,201903PJT,Commercialization,Hypoxia-activated DNA repair inhibitors to improve cancer therapy,573750,0,3 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,10/1/2019,9/30/2022,null,null,null
"Zhang, Li",University Health Network (Toronto),Ontario,Project Grant,201903PJT,Commercialization,"Developing a platform for ""off-the-shelf"" CAR-T cell therapies for cancer using double negative T cells",703800,0,4 yrs 0 mth ,Cancer Research,Commercialization-Technology Transfer; Cancer-Cancer Drug Development and Therapeutics,10/1/2019,9/30/2023,null,null,null
"Schweizer, Frank",University of Manitoba,Manitoba,Project Grant - Priority Announcement: Infection and Immunity,201909PJ4,Commercialization,Rescuing beta-lactam antibiotic/beta-lactamase inhibitor combinations from resistance against multidrug-resistant Gram-negative pathogens,100000,0,1 yr 0 mth  ,Infection and Immunity,"Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",3/1/2020,2/28/2021,null,null,null
"Schweizer, Frank",University of Manitoba,Manitoba,Project Grant,202003PJT,Commercialization,Rescuing beta-lactam antibiotic/beta-lactamase inhibitor combinations from resistance against multidrug-resistant Gram-negative pathogens,654075,0,4 yrs 0 mth ,Infection and Immunity,"Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",3/1/2020,2/28/2021,null,null,null
"Ma, Hongshen",University of British Columbia,British Columbia,Project Grant,201909PJT,Commercialization,Non-contact screening technology to expedite cell line development for antibody production,524026,0,3 yrs 0 mth ,Cancer Research,"Commercialization-Intellectual Property; Commercialization-Technology Transfer; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",4/1/2020,3/31/2023,null,null,null
"Biddiss, Elaine A",Holland Bloorview Kids Rehabilitation Hospital (Toronto),Ontario,Project Grant,201909PJT,Commercialization,"BootleBlast, a movement tracking video game for home-based motor therapy - Navigating gaps to market readiness",409276,0,3 yrs 0 mth ,"Human Development, Child and Youth Health",Commercialization-Technology Transfer,4/1/2020,3/31/2023,null,null,null
"Brinkman, Ryan",University of British Columbia,British Columbia,Project Grant,201909PJT,Commercialization,Machine Learning for Flow Cytometry Clinical Data and Trial Analysis,317475,0,1 yr 10 mths ,Infection and Immunity,Commercialization-Technology Transfer; Methods Development and Modelling-Quantitative Methods Development for Health Research,4/1/2020,1/31/2022,null,null,null
"Li, Shyh-Dar",University of British Columbia,British Columbia,Project Grant,201909PJT,Commercialization,Validation and commercialization of an innovative analgesic for chronic pain,524026,0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",4/1/2020,3/31/2023,null,null,null
"Kushki, Azadeh",Holland Bloorview Kids Rehabilitation Hospital (Toronto),Ontario,Project Grant,202003PJT,Commercialization,A wearable technology approach to managing challenging behaviours in children with autism spectrum disorder (ASD),485774,0,3 yrs 0 mth ,"Human Development, Child and Youth Health",Commercialization-Technology Transfer,10/1/2020,9/30/2023,null,null,null
"Olson, David M",University of Alberta,Alberta,Project Grant,202003PJT,Commercialization,Integrated discovery studies and commercialization for a preterm birth diagnostic and a therapeutic,558450,0,3 yrs 0 mth ,"Human Development, Child and Youth Health",Commercialization-Industry Research & Development; Reproduction and Development-Fertility and Maternal Health,10/1/2020,9/30/2023,null,null,null
"Boisselier Mailfait, Elodie",Universite Laval,Quebec,Project Grant,202003PJT,Commercialization,Un nouveau vecteur de medicaments ophtalmiques e base de nanoparticules d'or,550800,0,5 yrs 0 mth ,"Neurosciences, Mental Health and Addiction",Commercialization-Intellectual Property,10/1/2020,9/30/2025,null,null,null
"Drangova, Maria",Western University (Ontario),Ontario,Project Grant,202010PJT,Commercialization,Contact-force controller to eliminate the effects of motion during cardiac radiofrequency ablation,367200,0,2 yrs 0 mth ,Circulatory and Respiratory Health,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation",4/1/2021,3/31/2023,null,null,null
"Kizhakkedathu, Jayachandran N",University of British Columbia,British Columbia,Project Grant,202010PJT,Commercialization,Novel Infection Resistant Coating in an Era of Drug Resistant Bacteria for the Treatment and Prevention of Medical Device Infection,520199,0,3 yrs 0 mth ,Infection and Immunity,"Commercialization-Intellectual Property; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",4/1/2021,3/31/2024,null,null,null
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Project Grant - PA: Cancer Research - Cancer Prevention,202010PXX,Commercialization,Innovation of Proprietary Liquid Biopsy Assays for Diagnosis of Early Stage Ovarian Cancer,100000,0,1 yr 0 mth  ,Cancer Research,"Commercialization-Technology Transfer; Cancer-Cancer Progression and Metastasis; Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; glycomics. We quantify gangliosides which are glycolipids with a glycan and a lipid component",10/1/2021,9/30/2023,null,null,null
"Saragovi, Horacio U",CIUSSS de Centre-Ouest-de-l'Ile-de-Montreal-Jewish General,Quebec,Project Grant,202104PJT,Commercialization,Innovation of Proprietary Liquid Biopsy Assays for Diagnosis of Early Stage Ovarian Cancer,650251,0,2 yr 0 mth  ,Cancer Research,"Commercialization-Technology Transfer; Cancer-Cancer Progression and Metastasis; Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; glycomics. We quantify gangliosides which are glycolipids with a glycan and a lipid component",10/1/2021,9/30/2023,null,null,null
"Mossman, Karen L",McMaster University,Ontario,Project Grant,202104PJT,Commercialization,Clinical development of oncolytic BHV-1 for cancer therapy,504900,0,3 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Commercialization-Industry Research & Development; Cancer-Cancer Drug Development and Therapeutics,10/1/2021,9/30/2024,null,null,null
"Zeng, Haishan",University of British Columbia,British Columbia,Project Grant,202104PJT,Commercialization,Autofluorescence Imaging Guided Laser Raman Spectroscopy for Non-invasive Oral Cancer Detection,742051,0,4 yrs 0 mth ,Cancer Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation; Cancer-Clinical Oncology; Musculoskeletal Health-Oral Health",10/1/2021,9/30/2025,null,null,null
"Willerth, Stephanie M",University of Victoria (British Columbia),British Columbia,Project Grant,202104PJT,Commercialization,3D bioprinting next generation brain organoids for identifying drug targets for Alzheimer's disease,489600,0,4 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Biomedical Engineering-Regenerative Medicine and Tissue Engineering; Molecular, Cellular and Systems Biology-Cell Differentiation",10/1/2021,9/30/2025,null,null,null
"Leavitt, Blair R",University of British Columbia,British Columbia,Operating Grant - PA: Genetics (Bridge Funding: Research Priorities),202109OGB,Commercialization,Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.,100000,0,1 yr 0 mth ,Genetics,"Commercialization-Industry Research & Development; Neurosciences-Neurological disorders; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",3/1/2022,2/28/2023,null,null,null
"Haddad, Elie","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Project Grant - PA: Breast Cancer Research,202109PLL,Commercialization,Platform of synthetic specific promoters for immunotherapies and regenerative medicine,100000,0,1 yr 0 mth ,Cancer Research,Commercialization-Intellectual Property; Commercialization-Technology Transfer; Cancer-Cancer Drug Development and Therapeutics,3/1/2022,3/31/2023,null,null,null
"Sheardown, Heather D",McMaster University,Ontario,Project Grant,202109PJT,Commercialization,A novel eye drop platform to improve ocular therapies,531674,0,3 yrs 0 mth ,Aging,"Commercialization-Technology Transfer; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",4/1/2022,3/31/2025,null,null,null
"Wang, Yuzhuo",University of British Columbia,British Columbia,Project Grant,202109PJT,Commercialization,Optimization and Validation of MCT4-targeting Small Molecule Inhibitors for Treatment of Advanced Cancers,1147500,0,5 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Cancer-Cancer Drug Development and Therapeutics,4/1/2022,3/31/2027,null,null,null
"Qadura, Mohammad",Unity Health Toronto,Ontario,Project Grant,202109PJT,Commercialization,Artery Alert - Revolutionizing the Diagnosis of Peripheral Arterial Disease,428400,0,4 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Clinical and Translational Cardiovascular Sciences",4/1/2022,3/31/2026,null,null,null
"Leavitt, Blair R",University of British Columbia,British Columbia,Project Grant,202203PJT,Commercialization,Lipid Nanoparticle-Mediated Delivery of CRISPR/Cas9 Gene Editing for Neurological Disorders.,761176,0,5 yr 0 mth ,Genetics,"Commercialization-Industry Research & Development; Neurosciences-Neurological disorders; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",10/1/2022,9/30/2027,,,
"Gross, Peter L",McMaster University,Ontario,Project Grant,202203PJT,Commercialization,Benchmarking a point-of-care test kit for detection of direct-oral anticoagulants,279225,0,2 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Vascular and Endothelial Biology; Commercialization-Intellectual Property; Cardiovascular, Respiratory and Circulatory Systems-Hematology",10/1/2022,9/30/2024,null,null,null
"Yokota, Toshifumi",University of Alberta,Alberta,Project Grant,202203PJT,Commercialization,Commercializing a novel platform for delivery of antisense oligonucleotide-mediated therapy,1009800,0,5 yrs 0 mth ,Genetics,Genetics-Clinical Genetics,10/1/2022,9/30/2027,null,null,null
"Diamandis, Eleftherios P",Sinai Health System (Toronto),Ontario,Project Grant,202203PJT,Commercialization,"KaliDerm Therapeutics: A research/commercialization plan to validate, better define and add value to our proprietary dual KLK5/7 inhibitor as a novel topical therapeutic for Netherton Syndrome.",336600,0,2 yrs 0 mth ,Infection and Immunity,"Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",10/1/2022,9/30/2024,null,null,null
"Gong, Siew-Ging",University of Toronto,Ontario,Project Grant,202203PJT,Commercialization,Streptococcus salivarius Probiotics Against Dental Caries Pathogens,535501,0,4 yrs 0 mth ,Musculoskeletal Health and Arthritis,"Commercialization-Intellectual Property; Health Determinants-Etiology of Disease and Conditions; Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",10/1/2022,9/30/2026,null,null,null
"Beg, Mirza Faisal","Simon Fraser University (Burnaby, B.C.)",British Columbia,Project Grant - Priority Announcement: Cancer Research,202209PJS,Commercialization,Novel end-to-end platform for extraction of body composition measurements from CT images for research and integration into clinical workflows for precision medicine,100000,0,1 yr 0 mth ,Cancer Research,Biomedical Engineering-Biomedical Imaging; Artificial Intelligence-Machine Learning; Commercialization-Industry Research & Development,3/1/2023,2/29/2024,null,null,null
"DeWitte-Orr, Stephanie","Wilfrid Laurier University (Waterloo, Ontario)",Ontario,Project Grant - PA: Pandemic Preparedness and Health Emergencies Research,202209PPE,Commercialization,Developing intranasal dsRNA molecules as broadly effective therapeutics against highly pathogenic coronaviruses,100000,0,1 yr 0 mth ,Infection and Immunity,"Immunology and Infection-Virology; Commercialization-Intellectual Property; Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics",3/1/2023,2/29/2024,null,null,null
"Haddad, Elie","Centre hospitalier universitaire Sainte-Justine (Montreal, Quebec)",Quebec,Project Grant,202209PJT,Commercialization,Empowering innovative hematopoietic stem cells (HSC)-based cancer immunotherapy through the creation of synthetic specific promoters,765000,0,4 yrs 0 mth ,Cancer Research,Commercialization-Intellectual Property; Commercialization-Technology Transfer; Cancer-Cancer Drug Development and Therapeutics,4/1/2023,3/31/2027,null,null,null
"Kremer, Richard B",Research Institute of the McGill University Health Centre,Quebec,Project Grant,202209PJT,Commercialization,Anti-parathyroid hormone-related protein (PTHrP) monoclonal antibodies against metastatic cancer,665550,0,3 yrs 0 mth ,Cancer Research,"Commercialization-Technology Transfer; Musculoskeletal Health-Bone, Skin and Cartilage Sciences; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",4/1/2023,3/31/2026,null,null,null
"Mueller, Christopher R","Queen's University (Kingston, Ontario)",Ontario,Project Grant,202209PJT,Commercialization,Using a Liquid Biopsy to Optimize Metastatic Breast Cancer Treatment,891226,0,3 yrs 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis; Cancer-Clinical Oncology; Commercialization-Industry Research & Development,4/1/2023,3/31/2026,null,null,null
"Braverman, Nancy E",Research Institute of the McGill University Health Centre,Quebec,Project Grant,202209PJT,Commercialization,Enabling commercialization of retinal gene therapy for Zellweger Spectrum Disorder,1503225,0,5 yrs 0 mth ,Genetics,"Commercialization-Technology Transfer; Neurosciences-Sensory Systems (including visual, auditory and pain); Genetic disease",4/1/2023,3/31/2028,null,null,null
"Kizhakkedathu, Jayachandran N",University of British Columbia,British Columbia,Project Grant,202209PJT,Commercialization,Localized immuno-cloaking organ engineering approach to prevent transplant rejection without immunosuppressants,803250,0,3 yrs 0 mth ,Infection and Immunity,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Immunology and Infection-Transplantation, Immune Tolerance and Tumor Immunology; Commercialization-Intellectual Property",4/1/2023,3/31/2026,null,null,null
"Lubell, William D",Universite de Montreal,Quebec,Project Grant,202209PJT,Commercialization,"Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation",833851,0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Commercialization-Industry Research & Development; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Aging-Geriatric Medicine and Health Sciences",4/1/2023,3/31/2026,null,null,null
"Uludag, Hasan",University of Alberta,Alberta,Project Grant,202210PJT,Commercialization,New Treatment of Blood Cancers with Improved Delivery of Nucleic Acids,100000,0,1 yr 0 mth ,Cancer Research,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Cancer-Cancer Drug Development and Therapeutics; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery",4/1/2023,3/31/2024,null,null,null
"Unrau, Peter J","Simon Fraser University (Burnaby, B.C.)",British Columbia,Project Grant,202210PJT,Commercialization,Commercialization of RNA Mango fluorogenic aptamers: RNA Pulldown and Imaging Tools for Therapeutic and Diagnostic pipelines,100000,0,1 yr 0 mth ,Infection and Immunity,"Commercialization-Intellectual Property; Commercialization-Technology Transfer; Immunology and Infection-Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines)",4/1/2023,3/31/2024,null,null,null
"Akbari, Mohsen",University of Victoria (British Columbia),British Columbia,Project Grant,202303PJT,Commercialization,Towards commercialization of GelDerm-a smart dressing for continuous wound monitoring,332776,0,2 yrs 0 mth ,Musculoskeletal Health and Arthritis,Commercialization-Industry Research & Development,10/1/2023,9/30/2025,null,null,null
"Beg, Mirza Faisal","Simon Fraser University (Burnaby, B.C.)",British Columbia,Project Grant,202303PJT,Commercialization,Staging the host in Cancer: AI-based automated comprehensive body composition assessment for Precision Medicine,956250,0,3 yrs 0 mth ,Cancer Research,Biomedical Engineering-Biomedical Imaging; Artificial Intelligence-Machine Learning; Commercialization-Industry Research & Development,10/1/2023,9/30/2026,null,null,null
"Shlien, Adam",Hospital for Sick Children (Toronto),Ontario,Project Grant,202303PJT,Commercialization,Development of an RNA-based test for diagnosing and monitoring bone and soft tissue cancers,240976,0,1 yr 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis; Commercialization-Technology Transfer; Artificial Intelligence-Machine Learning,10/1/2023,9/30/2024,null,null,null
"Sutherland, Garnette R",University of Calgary,Alberta,Project Grant,202303PJT,Commercialization,An Intelligent Workstation for Robot-Assisted Microsurgery & Tele-Operations,780300,0,3 yrs 0 mth ,Health Services and Policy Research,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation",10/1/2023,9/30/2026,null,null,null
"Lubell, William D",Universite de Montreal,Quebec,Project Grant,202303PJT,Commercialization,Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration,516376,0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Commercialization-Industry Research & Development; Pharmacological, Toxicological and Pharmaceutical Sciences-Drug Discovery, Design and Delivery; Aging-Geriatric Medicine and Health Sciences",10/1/2023,9/30/2026,null,null,null
"Vanner, Stephen J","Queen's University (Kingston, Ontario)",Ontario,Project Grant,202303PJT,Commercialization,Developing a potent non-addictive analgesic as an alternative to conventional opioids,665550,0,3 yrs 0 mth ,"Neurosciences, Mental Health and Addiction","Commercialization-Industry Research & Development; Neurosciences-Sensory Systems (including visual, auditory and pain)",10/1/2023,9/30/2026,null,null,null
"Zaugg, Michael",University of Alberta,Alberta,Project Grant,202303PJT,Commercialization,"Vegaven, a novel lipid emulsion with unique superior biological actions designed for parenteral nutrition",818550,0,3 yrs 0 mth ,"Nutrition, Metabolism and Diabetes",Commercialization-Intellectual Property,10/1/2023,9/30/2026,null,null,null
"Foster, Leonard J",University of British Columbia,British Columbia,Project Grant - PA: Pandemic Preparedness and Health Emergencies Research,202309PPE,Commercialization,Development and Commercialization of a Safe and Effective Mpox Subunit Vaccine witheGlobaleImpact,100000,0,1 yr 0 mth ,Population and Public Health,"Population and Health-Health Promotion and Disease Prevention; Immunology and Infection-Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics (including vaccines)",3/1/2024,2/28/2025,null,null,null
"Chen, Yen-I",Research Institute of the McGill University Health Centre,Quebec,Project Grant,202309PJT,Commercialization,A novel through-the-scope exchangeable double balloon catheter to guide endoscopic bypass:  a practice-changing technology in the management of malignant gastric outlet obstruction,451350,0,2 yrs 0 mth ,"Nutrition, Metabolism and Diabetes",null,3/1/2024,2/28/2025,null,null,null
"Lin, Sheng-Xiang",Universite Laval,Quebec,Project Grant - PA: Breast Cancer Research,202309PLL,Commercialization,Pre-clinical pharmacokinetic and efficacy assays with an efficient 17beta-hydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy,100000,0,1 yr 0 mth ,Cancer Research,"Cancer-Cancer Drug Development and Therapeutics; Digestive, Endocrine and Excretory Systems-Endocrinology",3/1/2024,2/28/2025,null,null,null
"Alain, Tommy",Children's Hospital of Eastern Ontario Research Institute Inc,Ontario,Project Grant - PA: Breast Cancer Research,202309PLL,Commercialization,Viralyzing transgenes to improve oncolytic immunotherapy.,100000,0,1 yr 0 mth ,Cancer Research,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Genetics-Genomics, Transcriptomics and Proteomics; Immunology and Infection-Virology",4/1/2024,3/31/2025,null,null,null
"Garnis, Cathie",University of British Columbia,British Columbia,Project Grant,202309PJT,Commercialization,Blood based biomarker for the early detection of recurrent oropharyngeal cancer,474300,0,4 yrs 0 mth ,Cancer Research,Cancer-Cancer Progression and Metastasis; Cancer-Clinical Oncology,4/1/2024,3/31/2028,null,null,null
"Minchinton, Andrew I",University of British Columbia,British Columbia,Project Grant,202309PJT,Commercialization,Development of clinical candidate hypoxia-activated DNA-PK inhibitors,979200,0,4 yrs 0 mth ,Cancer Research,Cancer-Cancer Drug Development and Therapeutics,4/1/2024,3/31/2028,null,null,null
"Leonardi, Mathew",McMaster University,Ontario,Project Grant,202309PJT,Commercialization,Commercialization of a diagnostic test for endometriosis,634949,0,3 yrs 0 mth ,Gender and Health,"Sex-and-Gender Health-Sex-and-Gender-Based Analysis - Clinical, Health Systems and Population Health Research",4/1/2024,3/31/2027,null,null,null
"Pearson, Christopher E",Hospital for Sick Children (Toronto),Ontario,Project Grant,202309PJT,Commercialization,Pre-clinical studies of a small-molecule to reverse neurodegenerative disease-causing mutations for its commercialization and application,719101,0,3 yrs 0 mth ,Genetics,Commercialization-Technology Transfer; Genetics-Molecular and Functional Genetics and Epigenetics,4/1/2024,3/31/2027,null,null,null
"Alain, Tommy",Children's Hospital of Eastern Ontario Research Institute Inc,Ontario,Project Grant - PA: Breast Cancer Research,202403PLL,Commercialization,Viralyzing transgenes to improve oncolytic immunotherapy.,100000,0,1 yr 0 mth ,Cancer Research,"Biomedical Engineering-Biomaterials, Nanotechnology and Biomechanics; Genetics-Genomics, Transcriptomics and Proteomics; Immunology and Infection-Virology",10/1/2024,9/30/2025,null,null,null
"Daugaard, Mads",University of British Columbia,British Columbia,Project Grant,202403PJT,Commercialization,An integrated AI-powered platform for cell analytics,730576,0,4 yrs 0 mth ,Cancer Research,Commercialization-Technology Transfer; Artificial Intelligence-Machine Learning; Methods Development and Modelling-Qualitative Methods Development for Health Research,10/1/2024,9/30/2028,null,null,null
"Bear, Christine E",Hospital for Sick Children (Toronto),Ontario,Project Grant,202403PJT,Commercialization,Preclinical studies of a novel CFTR potentiator for commercialization as a therapy for chronic obstructive pulmonary disease.,325125,0,2 yrs 0 mth ,Circulatory and Respiratory Health,Commercialization-Technology Transfer,10/1/2024,9/30/2026,null,null,null
"Tavallaei, Mohammad A",Toronto Metropolitan University,Ontario,Project Grant,202403PJT,Commercialization,Design Revisions and Validations of a Catheter Steering and Navigation System For Peripheral Endovascular Revascularization,501076,0,3 yrs 0 mth ,Circulatory and Respiratory Health,"Biomedical Engineering-Biophysics, Medical Technologies and Instrumentation",10/1/2024,9/30/2027,null,null,null
"Walker, Gilbert C",University of Toronto,Ontario,Project Grant,202403PJT,Commercialization,Development of preclinical data for a phase one clinical trial of a micro-RNA-based formulation to treat early sepsis,508725,0,2 yrs 0 mth ,Circulatory and Respiratory Health,"Cardiovascular, Respiratory and Circulatory Systems-Respiratory System Pathologies and Clinical Interventions; Commercialization-Technology Transfer; Cardiovascular, Respiratory and Circulatory Systems-Clinical and Translational Cardiovascular Sciences",10/1/2024,9/30/2026,null,null,null
"Hysi, Eno",Unity Health Toronto,Ontario,Project Grant,202403PJT,Commercialization,Commercialization of H-scan: a new tool for imaging kidney fibrosis,726750,0,3 yrs 0 mth ,"Nutrition, Metabolism and Diabetes","Commercialization-Intellectual Property; Biomedical Engineering-Biomedical Imaging; Digestive, Endocrine and Excretory Systems-Nephrology and Urology",10/1/2024,9/30/2027,null,null,null
